{"SLR NAME":"The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis","References":[{"title1":"Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort","References":[{"title2":"Consensus for prevention and management of Coronavirus Disease 2019 (COVID-19) for neurologists","References":[{"title3":"Covid-19: WHO declares pandemic because of &quot;alarming levels&quot; of spread, severity, and inaction"},{"title3":"Single-Cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Notes from the field: isolation of 2019-nCoV from a stool specimen of a Laboratory-Confirmed case of the coronavirus disease 2019 (COVID-19)"},{"title3":"Diagnosis and treatment of the novel coronavirus pneumonia (Trial version 7) [D]. National Health Commission of the People's Republic of China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Possible central nervous system infection by SARS coronavirus"},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine Mig in pathogenesis"},{"title3":"Sars-Coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"Disease control letter of the General Office of the National Health Commission of the People's Republic of China [2020] No.65"},{"title3":"Recommendation of experts on prevention and control of new coronavirus infection in neurointerventional specialty (version 1) [D]"}]},{"title2":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized With COVID-19 in the New York City Area","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","References":[{"title3":"Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Tuberculosis and diabetes mellitus: convergence of two epidemics"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score"},{"title3":"Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity &amp; Mortality (HIMM) surveillance"},{"title3":"Summary of the 2018 report on cardiovascular diseases in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Burden of diabetes, hyperglycaemia in China from to 2016: findings from the 1990 to 2016, global burden of disease study"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis"},{"title3":"Connecting type 1 and type 2 diabetes through innate immunity"},{"title3":"Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing"}]},{"title2":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","References":[{"title3":"Epidemiological methods for studying genes and environmental factors in complex diseases"},{"title3":"Merging and emerging cohorts: not worth the wait"},{"title3":"Merging and emerging cohorts: necessary but not sufficient"},{"title3":"The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today"},{"title3":"UK Biobank: from concept to reality"},{"title3":"UK Biobank (2006). Protocol for a large-scale prospective epidemiological resource. www.ukbiobank.ac.uk/resources/."},{"title3":"Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology"},{"title3":"What makes a good genetic association study?"},{"title3":"What makes UK Biobank special?"},{"title3":"The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine"},{"title3":"Development and evaluation of the Oxford WebQ: a low cost web-based method for assessment of previous 24 hour dietary intake in large prospective studies"},{"title3":"Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies"},{"title3":"University of Leicester. About the 1958 Birth Cohort Study. http://www2.le.ac.uk/projects/birthcohort/1958bc/about. Accessed 12 October 2014"},{"title3":"Sax Institute. 45 and up study. https://www.saxinstitute.org.au/our-work/45-up-study/. Accessed 12 October 2014"},{"title3":"One in 30 people in the UK take part in cohort studies"},{"title3":"Design and implementation of a high-throughput biological sample processing facility using modern manufacturing principles"},{"title3":"Biorepositories:at the bleeding edge"},{"title3":"UK Biobank: a project in search of a protocol?"},{"title3":"UK Biobank (2007). Ethics and Governance Framework. www.ukbiobank.ac.uk/resources/. Accessed 12 October 2014."},{"title3":"UK Biobank (2011). Access Procedures: Application and review procedures for access to the UK Biobank Resource. www.ukbiobank.ac.uk/resources/. Accessed 12 October 2014."},{"title3":"Enhancing the feasibility of large cohort studies"}]},{"title2":"Covid-19: what is the UK's testing strategy?","References":[]},{"title2":"COVID-19 and the consequences of isolating the elderly","References":[{"title3":"Coronavirus: isolation for over-70s 'within weeks'"},{"title3":"Loneliness as a public health issue: the impact of loneliness on health care utilization among older adults"},{"title3":"Social disconnectedness, perceived isolation, and symptoms of depression and anxiety among older Americans (NSHAP): a longitudinal mediation analysis"},{"title3":"The value of maintaining social connections for mental health in older people"},{"title3":"Internet-based cognitive behavior therapy for loneliness: a pilot randomized controlled trial"}]},{"title2":"Dynamic linkage of COVID-19 test results between public health England's second generation surveillance system and UK Biobank","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"Epidemiology and unique aspects of aging and infectious diseases"},{"title3":"Microbial isolation in English participants in the UK Biobank cohort: comparison with the general population"},{"title3":"Denormalization strategies for data retrieval from data warehouses"},{"title3":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population"},{"title3":"Genetic susceptibility to infectious diseases: current status and future perspectives from genome-wide approaches"},{"title3":"Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections"},{"title3":"METAL: fast and efficient meta-analysis of genomewide association scans"}]},{"title2":"Hypertension in adults across the age spectrum: current outcomes and control in the community","References":[]},{"title2":"Association of blood pressure with clinical outcomes in older adults with chronic kidney disease","References":[{"title3":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization"},{"title3":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: Improving Global Outcomes 2012 Clinical Practice Guideline"},{"title3":"CKD prevalence varies across the European general population"},{"title3":"A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010"},{"title3":"The message for World Kidney Day 2009: hypertension and kidney disease - a marriage that should be prevented"},{"title3":"Cardio-kidney-damage: a unifying concept"},{"title3":"Age affects outcomes in chronic kidney disease"},{"title3":"ESH/ESC guidelines for the management of arterial hypertension"},{"title3":"KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease"},{"title3":"ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults"},{"title3":"Systolic BP and mortality in older adults with CKD"},{"title3":"Blood pressure trajectories in the 20 years before death"},{"title3":"A randomized trial of intensive versus standard blood-pressure control"},{"title3":"Data resource profile: Clinical Practice Research Datalink (CPRD)"},{"title3":"Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom"},{"title3":"Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study"},{"title3":"Hypertension and survival in chronic hemodialysis patients:past lessons and future opportunities"},{"title3":"A new equation to estimate glomerular filtration rate"},{"title3":"Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly"},{"title3":"Accuracy of electronic health record data for identifying stroke cases in large-scale epidemiological studies: a systematic review from the UK biobank stroke outcomes group"},{"title3":"Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis"},{"title3":"Adaptation and validation of the Charlson Index for Read/OXMIS coded databases"},{"title3":"A proportional hazards model for the subdistribution of a competing risk"},{"title3":"ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)"},{"title3":"Data resource profile: Clinical Practice Research Datalink (CPRD)"},{"title3":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization"},{"title3":"Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials"},{"title3":"Treatment of hypertension in patients 80 years of age or older"},{"title3":"Implications of blood pressure measurement technique for implementation of Systolic Blood Pressure Intervention Trial (SPRINT)"}]},{"title2":"CKD and risk for hospitalization with infection: the Atherosclerosis Risk in Communities (ARIC) study","References":[]},{"title2":"CKD and risk of hospitalization and death with pneumonia","References":[]},{"title2":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","References":[{"title3":"Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study"},{"title3":"Global burden of hypertension: analysis of worldwide data"},{"title3":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies"},{"title3":"Molecular mechanisms of human hypertension"},{"title3":"Genome-wide association study identifies eight loci associated with blood pressure"},{"title3":"Genome-wide association study of blood pressure and hypertension"},{"title3":"GOSR2 Lys67Arg is associated with hypertension in whites"},{"title3":"Associations between genetic variations in the FURIN gene and hypertension"},{"title3":"17alpha-hydroxylase/17,20-lyase deficiency caused by a novel homozygous mutation (Y27Stop) in the cytochrome CYP17 gene"},{"title3":"Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women"},{"title3":"Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991"},{"title3":"Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials"},{"title3":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies"},{"title3":"Blood pressure control in chronic kidney disease: is less really more?"},{"title3":"Estimation of effect size distribution from genome-wide association studies and implications for future discoveries"},{"title3":"Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure"},{"title3":"Purification and subunit composition of atrial natriuretic peptide receptor"},{"title3":"NO at work"},{"title3":"The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system"},{"title3":"Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase"},{"title3":"Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders"},{"title3":"Cloning, tissue distribution, genomic organization, and functional characterization of NBC3, a new member of the sodium bicarbonate cotransporter family"},{"title3":"Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible"},{"title3":"A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis"},{"title3":"Discovery of ZIP transporters that participate in cadmium damage to testis and kidney"},{"title3":"Biological, clinical and population relevance of 95 loci for blood lipids"},{"title3":"Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index"},{"title3":"Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians"}]},{"title2":"Atrial fibrillation and non-cardiovascular diseases: a systematic review","References":[{"title3":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association"},{"title3":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study"},{"title3":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study"},{"title3":"Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options - a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference"},{"title3":"Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study"},{"title3":"First diagnosis of colorectal or breast cancer and prevalence of atrial fibrillation"},{"title3":"Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients"},{"title3":"Colorectal cancer and risk of atrial fibrillation and flutter: a population-based case-control study"},{"title3":"Risk factors for atrial fibrillation after lung cancer surgery: analysis of the Society of Thoracic Surgeons general thoracic surgery database"},{"title3":"Prevalence and predictors of new-onset atrial fibrillation after elective surgery for colorectal cancer"},{"title3":"Insights into onco-cardiology: atrial fibrillation in cancer"},{"title3":"Inflammation and cancer"},{"title3":"Atrial fibrillation in chronic non-cardiac disease: here do we stand?"},{"title3":"Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study"},{"title3":"Atrial fibrillation and survival in colorectal cancer"},{"title3":"2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society"},{"title3":"Mechanisms of heparin induced anti-cancer activity in experimental cancer models"},{"title3":"Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism"},{"title3":"Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy"},{"title3":"Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer"},{"title3":"Atrial fibrillation after thoracic surgery for lung cancer: use of a single cut-off value of N-terminal pro-B type natriuretic peptide to identify patients at risk"},{"title3":"Predictive value of B-type natriuretic peptide for postoperative atrial fibrillation following pulmonary resection for lung cancer"},{"title3":"Predictive value of preoperative tissue Doppler echocardiographic analysis for postoperative atrial fibrillation after pulmonary resection for lung cancer"},{"title3":"Incidence and predictors of new-onset atrial fibrillation in noncardiac intensive care unit patients"},{"title3":"Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study"},{"title3":"Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review"},{"title3":"The immunopathogenesis of sepsis"},{"title3":"Severe sepsis and septic shock"},{"title3":"Paroxysmal atrial fibrillation in critically ill patients with sepsis"},{"title3":"Long-term outcomes following development of new-onset atrial fibrillation during sepsis"},{"title3":"Is severe sepsis associated with new-onset atrial fibrillation and stroke?"},{"title3":"Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study"},{"title3":"Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)"},{"title3":"COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program"},{"title3":"Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study"},{"title3":"Radiofrequency catheter ablation of atrial fibrillation in patients with chronic obstructive pulmonary disease: opportunity and challenge: response to Dr Kumar's comment"},{"title3":"Evaluation of atrial conduction features with tissue Doppler imaging in patients with chronic obstructive pulmonary disease"},{"title3":"Management of atrial fibrillation in patients with chronic obstructive pulmonary disease"},{"title3":"Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis"},{"title3":"The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease"},{"title3":"Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis"},{"title3":"Impact of chronic obstructive pulmonary disease on procedural outcomes and quality of life in patients with atrial fibrillation undergoing catheter ablation"},{"title3":"Increased prevalence of sleep-disordered breathing in adults"},{"title3":"Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study"},{"title3":"Obstructive sleep apnea and atrial fibrillation: understanding the connection"},{"title3":"Association of atrial fibrillation and obstructive sleep apnea"},{"title3":"Association of sleep-disordered breathing and the occurrence of stroke"},{"title3":"Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation"},{"title3":"Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study"},{"title3":"Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study"},{"title3":"C reactive protein in patients with chronic renal diseases"},{"title3":"Chronic kidney disease and atrial fibrillation"},{"title3":"Alterations of atrial electrophysiology induced by electrolyte variations: combined computational and P-wave analysis"},{"title3":"Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease"},{"title3":"Incident atrial fibrillation and risk of death in adults with chronic kidney disease"},{"title3":"Meta-analysis of the influence of chronic kidney disease on the risk of thromboembolism among patients with nonvalvular atrial fibrillation"},{"title3":"Stroke and bleeding in atrial fibrillation with chronic kidney disease"},{"title3":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study"},{"title3":"Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis"},{"title3":"C-reactive protein elevation in patients: inflammatory mechanisms and persistence of atrial fibrillation"},{"title3":"Inflammation as a risk factor for atrial fibrillation"},{"title3":"Inflammation in atrial fibrillation"},{"title3":"Incidence, severity and perioperative risk factors for atrial fibrillation following pulmonary resection"}]},{"title2":"Dementia care during COVID-19","References":[{"title3":"Current understanding of Alzheimer's disease diagnosis and treatment"},{"title3":"Best practice in the management of behavioural and psychological symptoms of dementia"},{"title3":"Behavioral and psychological symptoms of dementia"},{"title3":"Agitation and dementia: Prevention and treatment strategies in acute and chronic conditions"},{"title3":"Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia"},{"title3":"Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia"},{"title3":"Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition"},{"title3":"Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition"},{"title3":"Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence"},{"title3":"Quality of life in dementia: More than just cognition. An analysis of associations with quality of life in dementia"},{"title3":"Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: The Cache County Dementia Progression Study"},{"title3":"Neuropsychiatric symptoms and the risk of institutionalization and death: The aging, demographics, and memory study"},{"title3":"Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community"},{"title3":"The influence of the individual neuropsychiatric symptoms of people with Alzheimer disease on family caregiver distress-A longitudinal ALSOVA study"},{"title3":"The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease"},{"title3":"The American Psychiatric Association Practice Guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia"},{"title3":"The agitated older adult in the emergency department: A narrative review of common causes and management strategies"},{"title3":"Managing delirium and agitation in the older emergency department patient: The ADEPT Tool"},{"title3":"Reduction and prevention of agitation in persons with neurocognitive disorders: An international psychogeriatric association consensus algorithm"},{"title3":"Pharmacological management of agitation in emergency settings"},{"title3":"Pharmacological management of acute agitation"},{"title3":"Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia"},{"title3":"Use of benzodiazepines in Alzheimer's disease: A systematic review of literature"},{"title3":"Treatment options for acute agitation in psychiatric patients: Theoretical and empirical evidence"},{"title3":"Behavioral emergency in the elderly: A descriptive study of patients referred to an Aggression Response Team in an acute hospital"},{"title3":"Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia"},{"title3":"Pharmacologic management of agitation in patients with dementia"},{"title3":"Characterization of psychotropic PRN medications in a Canadian psychiatric intensive care unit"},{"title3":"In an emergency setting, what is the best intramuscular pharmacological treatment to give to an agitated geriatric patient?"},{"title3":"Impact of COVID-19 pandemic on mental health in the general population: A systematic review"},{"title3":"The COVID-19 pandemic's impact on older adults' mental health: Contributing factors, coping strategies, and opportunities for improvement"},{"title3":"The effect of COVID-19 isolation measures on the cognition and mental health of people living with dementia: A rapid systematic review of one year of quantitative evidence"},{"title3":"The effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis"},{"title3":"The effects of the COVID-19 pandemic on neuropsychiatric symptoms in dementia and carer mental health: An international multicentre study"},{"title3":"Behavioral and psychological effects of coronavirus disease-19 quarantine in patients with dementia"},{"title3":"Managing the impact of COVID-19 in nursing homes and long-term care facilities: An update"},{"title3":"Behavioral symptoms, depression symptoms, and medication use in Michigan nursing home residents with dementia during COVID-19"},{"title3":"Antipsychotic prescribing to people with dementia during COVID-19"},{"title3":"The course of neuropsychiatric symptoms and psychotropic drug use in Dutch nursing home patients with dementia during the first wave of COVID-19: A longitudinal cohort study"},{"title3":" Government of Ontario, Ontario Confirms First Case of Wuhan Novel Coronavirus, Government of Ontario, https://news.ontario.ca/en/release/55486/ontario-confirms-first-case-of-wuhan-novel-coronavirus, Accessed December 1, 2022."},{"title3":" Sunnybrook Health Sciences Centre, About Sunnybrook - Our Sites, https://sunnybrook.ca/content/?page=location, Accessed December 19, 2022."},{"title3":" Sunnybrook Veterans Centre, Sunnybrook - Resident and Family Information Guide,https://sunnybrook.ca/uploads/1/programs/veterans/sunnybrook-veterans-handbook-141103.pdf, Accessed December 19, 2022."},{"title3":" Sunnybrook Health Sciences Centre, Veterans Program - Dementia Care, https://sunnybrook.ca/content/?page=veterans-dementia-care-dorothy-macham-home, Accessed December 19, 2022."},{"title3":" Villa Charities, About Villa Colombo Toronto, https://www.villacharities.com/affilates/villa-colombo-toronto/about-villa-colombo-toronto/, Accessed December 19, 2022."},{"title3":" Government of Canada, Long-term facilities-based care, https://www.canada.ca/en/health-canada/services/home-continuing-care/long-term-facilities-based-care.html, Accessed April 1, 2023"},{"title3":" Canadian Institute for Health Information, Long-term care homes in Canada: How many and who owns them?https://www.cihi.ca/en/long-term-care-homes-in-canada-how-many-and-who-owns-them, Accessed April 1, 2023."},{"title3":" Government of Ontario, Paying for long-term care, https://www.ontario.ca/page/paying-long-term-care, Accessed April 1, 2023."},{"title3":"Increased prescribing of psychotropic medications to Ontario nursing home residents during the COVID-19 pandemic"},{"title3":"Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings"},{"title3":"COVID-19 epidemic in Argentina: Worsening of behavioral symptoms in elderly subjects with dementia living in the community"},{"title3":"Psychotropic drug prescription in nursing homes during the COVID-19 pandemic"},{"title3":"Impact of social isolation due to COVID-19 on health in older people: Mental and physical effects and recommendations"},{"title3":"Dementia and mental health during the COVID-19 pandemic: A systematic review"},{"title3":"Effects of COVID-19 pandemic confinement in patients with cognitive impairment"},{"title3":"Facing dementia during the COVID-19 outbreak"},{"title3":"Neuropsychiatric symptoms in elderly with dementia during COVID-19 pandemic: Definition, treatment, and future directions"},{"title3":" Public Health Agency of Canada, Infection prevention and control for COVID-19: Interim guidance for long term care homes, https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevent-control-covid-19-long-term-care-homes.html, Accessed December 21, 2022."},{"title3":"Amid the COVID-19 pandemic, meaningful communication between family caregivers and residents of long-term care facilities is imperative"},{"title3":"The effects of the 2020 COVID-19 lockdown on mood, behavior, and social and cognitive functioning in older long-term care residents"},{"title3":"The effectiveness of non-pharmacological interventions using information and communication technologies for behavioral and psychological symptoms of dementia: A systematic review and meta-analysis"},{"title3":"COVID-19 and Ontario's long-term care homes"},{"title3":"Position statement for mental health care in long-term care during COVID-19"},{"title3":"Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)"},{"title3":"Haloperidol plus promethazine for psychosis-induced aggression"},{"title3":"A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation"},{"title3":"Use of antipsychotics in patients with behavioral and psychological symptoms of dementia: Results of a Spanish Delphi Consensus"},{"title3":"Managing acute agitation and aggression in the world of drug shortages"},{"title3":"Hypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam"},{"title3":"Treatment of agitation with lorazepam in clinical practice: A systematic review"},{"title3":"Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department"},{"title3":"The old and the oldest-old: Do they have different perspectives on adjustment to aging? "},{"title3":"Antipsychotic use in dementia"},{"title3":"Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations"},{"title3":" UN News, COVID-19: China infection surge on agenda at WHO coronavirus meeting, United Nations, https://news.un.org/en/story/2023/01/1132132, Accessed January 20, 2023."}]},{"title2":"APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort","References":[{"title3":"Clinical and immunological features of severe and moderate coronavirus disease 2019"},{"title3":"Sensing damage by the NLRP3 inflammasome"},{"title3":"Hypertension and COVID-19"},{"title3":"Clinical characteristics of patients who died of coronavirus disease 2019 in China"},{"title3":"Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO clinical characterisation protocol"},{"title3":"ApoE in Atherosclerosis"},{"title3":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies"},{"title3":"Impact of hypertension on cognitive function: a scientific statement from the American Heart Association"},{"title3":"APOE E4 genotype predicts severe COVID-19 in the UK Biobank community cohort"},{"title3":"ApoEe4e4 genotype and mortality with COVID-19 in UK Biobank"},{"title3":"APOepsilon4 is associated with enhanced in vivo innate immune responses in human subjects"},{"title3":"Immediate and long-term consequences of COVID-19 infections for the development of neurological disease"},{"title3":"Neurologic features in severe SARS-CoV-2 infection"},{"title3":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China"},{"title3":"APOE genotype-dependent modulation of astrocyte chemokine CCL3 production"},{"title3":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline"},{"title3":"Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes"},{"title3":"COVID-19 and African Americans"},{"title3":"The effects of APOE and ABCA7 on cognitive function and Alzheimer's disease risk in african americans: a focused mini review"},{"title3":"COVID-19: immunology and treatment options"},{"title3":"APOE-modulated Abeta-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective"}]},{"title2":"ApoE e4e4 genotype and mortality with COVID-19 in UK Biobank","References":[{"title3":"APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort"},{"title3":"ApoE e4e4 genotype and mortality with COVID-19 in UK Biobank"},{"title3":"Preexisting comorbidities predicting COVID-19 and mortality in the UK Biobank community cohort"},{"title3":"Estimation of significance thresholds for genomewide association scans"},{"title3":"Estimating genome-wide significance for whole-genome sequencing studies"},{"title3":"The (in)famous GWAS P-value threshold revisited and updated for low-frequency variants"},{"title3":"Replicating genotype-phenotype associations"}]},{"title2":"Interpreting a covid-19 test result","References":[]},{"title2":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","References":[{"title3":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age"},{"title3":"Bias"},{"title3":"New models for large prospective studies: is there a better way?"},{"title3":"Representativeness of participants in a cross-sectional health survey by time of day and day of week of data collection"},{"title3":"Cohort profile: the Health Survey for England"},{"title3":"Comparison of the sociodemographic characteristics of the large NutriNet-Sante e-cohort with French Census data: the issue of volunteer bias revisited"},{"title3":"Recruitment via the Internet and social networking sites: the 1989-1995 cohort of the Australian Longitudinal Study on Women's Health"},{"title3":"Women's Health Australia: recruitment for a national longitudinal cohort study"},{"title3":"Mortality and cancer incidence in the EPIC-NL cohort: impact of the healthy volunteer effect"},{"title3":"Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?"},{"title3":"Evidence of a healthy volunteer effect in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial"},{"title3":"Healthy volunteer effect in a cohort study: temporal resolution in the Adventist Health Study"},{"title3":"Can large surveys conducted on highly selected populations provide valid information on the epidemiology of common health conditions? An analysis of UK Biobank data on musculoskeletal pain"},{"title3":"Why representativeness should be avoided"},{"title3":"Commentary: should we always deliberately be non-representative?"},{"title3":"Commentary: on representativeness"},{"title3":"Commentary: representativeness is usually not necessary and often should be avoided"},{"title3":"UK Biobank: current status and what it means for epidemiology"},{"title3":"What makes UK Biobank special?"},{"title3":"A structural approach to selection bias"},{"title3":"Association of cardiometabolic multimorbidity with mortality"},{"title3":"5 year mortality predictors in 498 103 UK Biobank participants: a prospective population-based study"},{"title3":"Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials"}]},{"title2":"Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"COVID-19 in Europe: the Italian lesson."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Government of Italy decree of the president of the Council of Ministers 9 March 2020 (). (In Italian.)"},{"title3":"L'andamento dei decessi del 2020. Dati anticipatori sulla base del sistema ANPR. Istat, March 31, 2020 (). (In Italian.)"}]},{"title2":"Age is just a number:and so is frailty: strategies to inform resource allocation during the COVID-19 pandemic","References":[{"title3":"Facing Covid-19 in Italy : ethics, logistics, and therapeutics on the epidemic's front line"},{"title3":", , . Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA [Internet]. March 23, 2020. [cited March 24, 2020]; Available at:  (accessed )."},{"title3":"Heterogeneity of human aging and its assessment"},{"title3":"Fair allocation of scarce medical resources in the time of Covid-19"},{"title3":"Overview | COVID-19 rapid guideline: critical care | Guidance | NICE [Internet]. NICE; [cited 2020 Mar 24]. Available at:  (accessed )."},{"title3":"Frailty in older adults: evidence for a phenotype"},{"title3":"Prevalence of frailty in Canadians 18-79 years old in the Canadian Health Measures Survey"},{"title3":"A global clinical measure of fitness and frailty in elderly people"},{"title3":"Which frailty scale for patients admitted via emergency department? A cohort study"},{"title3":"Demographic science aids in understanding the spread and fatality rates of COVID-19"}]},{"title2":"Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science","References":[{"title3":"Mental health and wellbeing in England: Adult Psychiatric Morbidity Survey 2014"},{"title3":"Data resource profile: the mental health of children and young people surveys (MHCYP)"},{"title3":"Psychological treatments: a call for mental-health science"},{"title3":"Covid-19 and mental wellbeing"},{"title3":"COVID-19: a living systematic map of the evidence"},{"title3":"A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations"},{"title3":"Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019"},{"title3":"Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China"},{"title3":"Online mental health services in China during the COVID-19 outbreak"},{"title3":"Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China"},{"title3":"The effects of social support on sleep quality of medical staff treating patients with coronavirus disease 2019 (COVID-19) in January and February 2020 in China"},{"title3":"The impact of COVID-19 epidemic declaration on psychological consequences: a study on active Weibo users"},{"title3":"The psychological impact of quarantine and how to reduce it: rapid review of the evidence"},{"title3":"Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control"},{"title3":"Mental health survey of 230 medical staff in a tertiary infectious disease hospital for COVID-19"},{"title3":"Gunnell D, Appleby L, Arensman E, et al. Suicide risk and prevention during the COVID-19 pandemic. Lancet Psychiatry (in press)."},{"title3":"The impact of epidemic outbreak: the case of severe acute respiratory syndrome (SARS) and suicide among older adults in Hong Kong"},{"title3":"Psychosocial impact of SARS"},{"title3":"Psychosocial effects of SARS on hospital staff: survey of a large tertiary care institution"},{"title3":"The psychology of suicidal behaviour"},{"title3":"Self-harm, suicidal behaviours, and cyberbullying in children and young people: systematic review"},{"title3":"Suicide and suicide risk"},{"title3":"Contribution of risk factors to excess mortality in isolated and lonely individuals: an analysis of data from the UK Biobank cohort study"},{"title3":"Lonely young adults in modern Britain: findings from an epidemiological cohort study"},{"title3":"The integrated motivational-volitional model of suicidal behaviour"},{"title3":"Suicide: media impacts in war and peace, 1910-1920"},{"title3":"Suicides associated with the 2008-10 economic recession in England: time trend analysis"},{"title3":"Mental health outcomes in times of economic recession: a systematic literature review"},{"title3":"Problems and solutions in calculating quality-adjusted life years (QALYs)"},{"title3":"The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science"},{"title3":"Mediators and mechanisms of change in psychotherapy research"},{"title3":"Psychological and pharmacological treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized controlled trials"},{"title3":"Psychosocial interventions following self-harm in adults: a systematic review and meta-analysis"},{"title3":"Component studies of psychological treatments of adult depression: a systematic review and meta-analysis"},{"title3":"Cognitive-behavioural therapy and personalized treatment: an introduction to the special issue"},{"title3":"Suicide prevention using self-guided digital interventions: a systematic review and meta-analysis of randomised controlled trials"},{"title3":"What works and what doesn't work? A systematic review of digital mental health interventions for depression and anxiety in young people"},{"title3":"Digital mental health interventions for depression, anxiety and enhancement of psychological well-being among college students: systematic review"},{"title3":"National confidential inquiry into suicide and homicide by people with mental illness"},{"title3":"Digital exclusion among mental health service users: qualitative investigation"},{"title3":"Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety"},{"title3":"Looking to the future: a synthesis of new developments and challenges in suicide research and prevention"},{"title3":"Coping: pitfalls and promise"},{"title3":"No man is an island: social resources, stress and mental health at mid-life"},{"title3":"Psychological interventions for people affected by the COVID-19 epidemic"},{"title3":"A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression"},{"title3":"Stress, cortisol and suicide risk"},{"title3":"Problem Management Plus (PM+): a WHO transdiagnostic psychological intervention for common mental health problems"},{"title3":"Social support interventions: do they work?"},{"title3":"Exercise as medicine for mental and substance use disorders: a meta-review of the benefits for neuropsychiatric and cognitive outcomes"},{"title3":"Engagement in socially and interpersonally rewarding activities as a predictor of outcome in &quot;Engage&quot; behavioral activation therapy for late-life depression"},{"title3":"Feeling better at work! Mental health self-management strategies for workers with depressive and anxiety symptoms"},{"title3":"Terms 'physical distancing' and 'emotional closeness' should be used and not 'social distancing' when defeating the Covid-19 pandemic"},{"title3":"The global syndemic of obesity, undernutrition, and climate change: The Lancet Commission report"},{"title3":"The impact of communications about swine flu (influenza A H1N1v) on public responses to the outbreak: results from 36 national telephone surveys in the UK"},{"title3":"Avoidance behaviors and negative psychological responses in the general population in the initial stage of the H1N1 pandemic in Hong Kong"},{"title3":"Social isolation in mental health: a conceptual and methodological review"},{"title3":"Loneliness as a specific risk factor for depressive symptoms: cross-sectional and longitudinal analyses"},{"title3":"Patients with mental health disorders in the COVID-19 epidemic"},{"title3":"Annual research review: secular trends in child and adolescent mental health"},{"title3":"Cross-cohort change in adolescent outcomes for children with mental health problems"},{"title3":"Mental health interventions in schools in high-income countries"},{"title3":"Preventing childhood anxiety disorders: is an applied game as effective as a cognitive behavioral therapy-based program?"},{"title3":"COVID-19 and the consequences of isolating the elderly"},{"title3":"Survivors' priority themes and questions for research"},{"title3":"The COVID-19 pandemic: the 'black swan' for mental health care and a turning point for e-health"},{"title3":"Of mice and mental health: facilitating dialogue and seeing further"},{"title3":"OxIS 2019: Digital divides in Britain are narrowing but deepening"},{"title3":"Interpretation training to target repetitive negative thinking in generalized anxiety disorder and depression"},{"title3":"Advancing social connection as a public health priority in the United States"},{"title3":"Addressing social isolation to improve the health of older adults: a rapid review"},{"title3":"Pocket psychiatry: mobile mental-health apps have exploded onto the market, but few have been thoroughly tested"},{"title3":"Media messages and perception of risk for Ebola virus infection, United States"},{"title3":"Systematic literature review on the spread of health-related misinformation on social media"},{"title3":"To fear or not to fear? Applying the social amplification of risk framework on two environmental health risks in Singapore"},{"title3":"Distress, worry, and functioning following a global health crisis: a national study of Americans' responses to Ebola"},{"title3":"Media exposure to mass violence events can fuel a cycle of distress"},{"title3":"The novel coronavirus (COVID-2019) outbreak: amplification of public health consequences by media exposure"},{"title3":"Slowing down the COVID-19 outbreak: changing behaviour by understanding it"},{"title3":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions"},{"title3":"Psychological investigation of the structure of paranoia in a non-clinical population"},{"title3":"Threatening communication: a critical re-analysis and a revised meta-analytic test of fear appeal theory"},{"title3":"A Century of public health marketing: enduring public health challenges and revolutions in communication"},{"title3":"The ecology of emerging neurotropic viruses"},{"title3":"Coronavirus infection of rat dorsal root ganglia: ultrastructural characterization of viral replication, transfer, and the early response of satellite cells"},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis"},{"title3":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Neurological manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China"},{"title3":"COVID-19: Neurologists in Italy to colleagues in US: look for poorly-defined neurologic conditions in patients with the coronavirus"},{"title3":"The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients"},{"title3":"The relationship between encephalitis lethargica and influenza: a critical analysis"},{"title3":"Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?"},{"title3":"Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43"},{"title3":"Immunofluorescence studies on the pathogenesis of hemagglutinating encephalomyelitis virus infection in pigs after oronasal inoculation"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients"},{"title3":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Activation of human monocytes after infection by human coronavirus 229E"},{"title3":"Clinical and immunologic features in severe and moderate coronavirus disease 2019"},{"title3":"From inflammation to sickness and depression: when the immune system subjugates the brain"},{"title3":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)"},{"title3":"Pathogenesis of murine coronavirus in the central nervous system"},{"title3":"History of postviral fatigue syndrome"},{"title3":"Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever"},{"title3":"Postinfectious fatigue: prospective cohort study in primary care"},{"title3":"Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Focusing on the unfolded protein response and autophagy related pathways to reposition common approved drugs against COVID-19"},{"title3":"Data resource profile: clinical practice research datalink (CPRD)"},{"title3":"The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data"},{"title3":"CogStack - experiences of deploying integrated information retrieval and extraction services in a large National Health Service Foundation Trust hospital"},{"title3":"Ethical and legal challenges posed by severe acute respiratory syndrome: implications for the control of severe infectious disease threats"},{"title3":"Key ethical questions for research during the COVID-19 pandemic"},{"title3":"Rapid policy briefing: ethical considerations in responding to the COVID-19 pandemic"},{"title3":"What's next for registered reports?"},{"title3":"Toward a global health approach: lessons from the HIV and Ebola epidemics"}]}]},{"title1":"Clinical Presentation of COVID19 in Dementia Patients","References":[{"title2":"Word Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 79. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200408-sitrep-79-covid-19.pdf?sfvrsn=4796bl43_4","References":[]},{"title2":"Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. Published online March 23, 2020. doi:10.1001/jama.2020.4683","References":[]},{"title2":"Italian Study Group on Delirium (ISGoD). Delirium, Dementia, and In-Hospital Mortality: The Results From the Italian Delirium Day 2016, A National Multicenter Study","References":[]},{"title2":"D'Adamo H, Yoshikawa T, Ouslander JG. Coronavirus Disease 2019 in Geriatrics and Long-term Care: The ABCDs of COVID-19. JAGS 2020;doi: 10.1111/jgs.16445","References":[]},{"title2":"A new clinical scale for the staging of dementia","References":[]},{"title2":"Dementia care during COVID-19","References":[{"title3":"Current understanding of Alzheimer's disease diagnosis and treatment"},{"title3":"Best practice in the management of behavioural and psychological symptoms of dementia"},{"title3":"Behavioral and psychological symptoms of dementia"},{"title3":"Agitation and dementia: Prevention and treatment strategies in acute and chronic conditions"},{"title3":"Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia"},{"title3":"Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia"},{"title3":"Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition"},{"title3":"Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition"},{"title3":"Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence"},{"title3":"Quality of life in dementia: More than just cognition. An analysis of associations with quality of life in dementia"},{"title3":"Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: The Cache County Dementia Progression Study"},{"title3":"Neuropsychiatric symptoms and the risk of institutionalization and death: The aging, demographics, and memory study"},{"title3":"Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community"},{"title3":"The influence of the individual neuropsychiatric symptoms of people with Alzheimer disease on family caregiver distress-A longitudinal ALSOVA study"},{"title3":"The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease"},{"title3":"The American Psychiatric Association Practice Guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia"},{"title3":"The agitated older adult in the emergency department: A narrative review of common causes and management strategies"},{"title3":"Managing delirium and agitation in the older emergency department patient: The ADEPT Tool"},{"title3":"Reduction and prevention of agitation in persons with neurocognitive disorders: An international psychogeriatric association consensus algorithm"},{"title3":"Pharmacological management of agitation in emergency settings"},{"title3":"Pharmacological management of acute agitation"},{"title3":"Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia"},{"title3":"Use of benzodiazepines in Alzheimer's disease: A systematic review of literature"},{"title3":"Treatment options for acute agitation in psychiatric patients: Theoretical and empirical evidence"},{"title3":"Behavioral emergency in the elderly: A descriptive study of patients referred to an Aggression Response Team in an acute hospital"},{"title3":"Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia"},{"title3":"Pharmacologic management of agitation in patients with dementia"},{"title3":"Characterization of psychotropic PRN medications in a Canadian psychiatric intensive care unit"},{"title3":"In an emergency setting, what is the best intramuscular pharmacological treatment to give to an agitated geriatric patient?"},{"title3":"Impact of COVID-19 pandemic on mental health in the general population: A systematic review"},{"title3":"The COVID-19 pandemic's impact on older adults' mental health: Contributing factors, coping strategies, and opportunities for improvement"},{"title3":"The effect of COVID-19 isolation measures on the cognition and mental health of people living with dementia: A rapid systematic review of one year of quantitative evidence"},{"title3":"The effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis"},{"title3":"The effects of the COVID-19 pandemic on neuropsychiatric symptoms in dementia and carer mental health: An international multicentre study"},{"title3":"Behavioral and psychological effects of coronavirus disease-19 quarantine in patients with dementia"},{"title3":"Managing the impact of COVID-19 in nursing homes and long-term care facilities: An update"},{"title3":"Behavioral symptoms, depression symptoms, and medication use in Michigan nursing home residents with dementia during COVID-19"},{"title3":"Antipsychotic prescribing to people with dementia during COVID-19"},{"title3":"The course of neuropsychiatric symptoms and psychotropic drug use in Dutch nursing home patients with dementia during the first wave of COVID-19: A longitudinal cohort study"},{"title3":" Government of Ontario, Ontario Confirms First Case of Wuhan Novel Coronavirus, Government of Ontario, https://news.ontario.ca/en/release/55486/ontario-confirms-first-case-of-wuhan-novel-coronavirus, Accessed December 1, 2022."},{"title3":" Sunnybrook Health Sciences Centre, About Sunnybrook - Our Sites, https://sunnybrook.ca/content/?page=location, Accessed December 19, 2022."},{"title3":" Sunnybrook Veterans Centre, Sunnybrook - Resident and Family Information Guide,https://sunnybrook.ca/uploads/1/programs/veterans/sunnybrook-veterans-handbook-141103.pdf, Accessed December 19, 2022."},{"title3":" Sunnybrook Health Sciences Centre, Veterans Program - Dementia Care, https://sunnybrook.ca/content/?page=veterans-dementia-care-dorothy-macham-home, Accessed December 19, 2022."},{"title3":" Villa Charities, About Villa Colombo Toronto, https://www.villacharities.com/affilates/villa-colombo-toronto/about-villa-colombo-toronto/, Accessed December 19, 2022."},{"title3":" Government of Canada, Long-term facilities-based care, https://www.canada.ca/en/health-canada/services/home-continuing-care/long-term-facilities-based-care.html, Accessed April 1, 2023"},{"title3":" Canadian Institute for Health Information, Long-term care homes in Canada: How many and who owns them?https://www.cihi.ca/en/long-term-care-homes-in-canada-how-many-and-who-owns-them, Accessed April 1, 2023."},{"title3":" Government of Ontario, Paying for long-term care, https://www.ontario.ca/page/paying-long-term-care, Accessed April 1, 2023."},{"title3":"Increased prescribing of psychotropic medications to Ontario nursing home residents during the COVID-19 pandemic"},{"title3":"Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings"},{"title3":"COVID-19 epidemic in Argentina: Worsening of behavioral symptoms in elderly subjects with dementia living in the community"},{"title3":"Psychotropic drug prescription in nursing homes during the COVID-19 pandemic"},{"title3":"Impact of social isolation due to COVID-19 on health in older people: Mental and physical effects and recommendations"},{"title3":"Dementia and mental health during the COVID-19 pandemic: A systematic review"},{"title3":"Effects of COVID-19 pandemic confinement in patients with cognitive impairment"},{"title3":"Facing dementia during the COVID-19 outbreak"},{"title3":"Neuropsychiatric symptoms in elderly with dementia during COVID-19 pandemic: Definition, treatment, and future directions"},{"title3":" Public Health Agency of Canada, Infection prevention and control for COVID-19: Interim guidance for long term care homes, https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevent-control-covid-19-long-term-care-homes.html, Accessed December 21, 2022."},{"title3":"Amid the COVID-19 pandemic, meaningful communication between family caregivers and residents of long-term care facilities is imperative"},{"title3":"The effects of the 2020 COVID-19 lockdown on mood, behavior, and social and cognitive functioning in older long-term care residents"},{"title3":"The effectiveness of non-pharmacological interventions using information and communication technologies for behavioral and psychological symptoms of dementia: A systematic review and meta-analysis"},{"title3":"COVID-19 and Ontario's long-term care homes"},{"title3":"Position statement for mental health care in long-term care during COVID-19"},{"title3":"Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)"},{"title3":"Haloperidol plus promethazine for psychosis-induced aggression"},{"title3":"A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation"},{"title3":"Use of antipsychotics in patients with behavioral and psychological symptoms of dementia: Results of a Spanish Delphi Consensus"},{"title3":"Managing acute agitation and aggression in the world of drug shortages"},{"title3":"Hypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam"},{"title3":"Treatment of agitation with lorazepam in clinical practice: A systematic review"},{"title3":"Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department"},{"title3":"The old and the oldest-old: Do they have different perspectives on adjustment to aging? "},{"title3":"Antipsychotic use in dementia"},{"title3":"Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations"},{"title3":" UN News, COVID-19: China infection surge on agenda at WHO coronavirus meeting, United Nations, https://news.un.org/en/story/2023/01/1132132, Accessed January 20, 2023."}]},{"title2":"Aprahamian I, Cesari M. Geriatric Syndromes and SARS-COV-2: More than Just Being Old [published online ahead of print,]. J Frailty Aging. 2020;1-3. doi:10.14283/jfa.2020.17","References":[]},{"title2":"Jackson TA, Gladman JR, Harwood RH et al. Challenges and opportunities in understanding dementia and delirium in the acute hospital. PLoS Med:e 2017;1002247.","References":[]}]},{"title1":"Prognosis analysis of patients with mental disorders with COVID-19: a single-center retrospective study","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in wuhan, China.","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020"}]},{"title2":"Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China.","References":[]},{"title2":"COVID-19 infection in a patient with end-stage kidney disease.","References":[{"title3":"Coronavirus disease 2019 and influenza"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"}]},{"title2":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Notice on prevention and control of pneumonia in children and pregnant women with new coronavirus infection"},{"title3":"New coronavirus pneumonia prevention and control program (4th edn)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"The Spanish flu in Iceland 1918. Lessons in medicine and history"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Novel 2019 coronavirus genome"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Rubella and pregnancy: diagnosis, management and outcomes"},{"title3":"Wuhan Tongji Hospital diagnoses first case of neonatal infection with new coronavirus"},{"title3":"Neonatal coronavirus expert confirmed at 30 hours of birth: vertical transmission from mother to infant"}]},{"title2":"Inflammatory biomarkers predict domain-specific cognitive decline in older adults.","References":[]},{"title2":"Paeoniflorin improves regional cerebral blood flow and suppresses inflammatory factors in the hippocampus of rats with vascular dementia.","References":[]},{"title2":"Markers of low-grade inflammation and endothelial dysfunction are related to reduced information processing speed and executive functioning in an older population - the hoorn study.","References":[]},{"title2":"Plasma cytokines profile in older subjects with late onset alzheimer's disease or vascular dementia.","References":[]},{"title2":"The interleukin-6 inflammation pathway from cholesterol to aging:role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases.","References":[{"title3":"The immune system in aging: roles of cytokines, T cells and NK cells"},{"title3":"Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence"},{"title3":"Atherosclerosis an inflammatory disease"},{"title3":"Inflammation and atherosclerosis"},{"title3":"Cell biology of atherosclerosis"},{"title3":"Free cholesterol-induced cytotoxicity. A possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions"},{"title3":"Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects"},{"title3":"Cell death in atherosclerotic plaques"},{"title3":"Statin effects beyond lipid lowering - are they clinically relevant?"},{"title3":"Mechanisms of action of statins and their pleiotropic effects [Article in French]"},{"title3":"Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?"},{"title3":"Interleukin-6 and the acute phase response"},{"title3":"Elevated levels of interleukin-6 in unstable angina"},{"title3":"Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increasing risk of in-hospital coronary events"},{"title3":"Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation"},{"title3":"Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction"},{"title3":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men"},{"title3":"A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study"},{"title3":"Elevation of C-reactive protein in &quot;active&quot; coronary artery disease"},{"title3":"Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III"},{"title3":"C-reactive protein, inflammation, and coronary risk"},{"title3":"Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators"},{"title3":"High levels of plasma C-reactive protein and future risk of age-related cataract"},{"title3":"Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease"},{"title3":"Inflammatory markers and onset of cardiovascular events: results from the Health ABC study"},{"title3":"Medical Biochemistry Course Guide, 2004"},{"title3":"Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK"},{"title3":"Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study)"},{"title3":"Inflammatory markers and cognition in well-functioning African-American and white elders"},{"title3":"IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release"},{"title3":"Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6"},{"title3":"Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis"},{"title3":"Local levels of interleukin-1beta, -4, -6 and tumor necrosis factor alpha in an experimental model of murine osteomyelitis due to staphylococcus aureus"},{"title3":"Surface-associated protein from Staphylococcus aureus stimulates osteoclastogenesis: possible role in S. aureus-induced bone pathology"},{"title3":"Internalization of Mycobacterium bovis Bacillus Calmette-Guerin into osteoblast-like MC3T3-E1 cells and bone resorptive responses of the cells against the infection"},{"title3":"Chronic stress and age-related increases in the proinflammatory cytokine IL-6"},{"title3":"Life stress, mood disturbance, and elevated interleukin-6 in healthy older women"},{"title3":"Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway"},{"title3":"STATs and gene regulation"},{"title3":"Advances in interleukin-6 therapy"},{"title3":"Signaling mechanisms through gp130: a model of the cytokine system"},{"title3":"IL-6-regulated transcription factors"},{"title3":"The regulation of AP-1 activity by mitogen-activated protein kinases"},{"title3":"Multiple nuclear factors interact with the immunoglobulin enhancer sequences"},{"title3":"Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappabeta"},{"title3":"The transcriptional activity of NF-kappabeta is regulated by the I-kappabeta-associated PKAc subunit through a cyclic AMP-independent mechanism"},{"title3":"Rel/NFkappabeta/Ikappabeta family: intimate tales of association and dissociation"},{"title3":"Site-specific phosphorylation of Ikappabetaalpha by a novel ubiquitination-dependent pathway"},{"title3":"Function and activation of NF-kappaB 1995 Rel/NF T 1996 Site-specific phosphorylation of Iin vitro cell mediated immune assay predicts in vivo response"},{"title3":"Rel/NFkappabeta/Ikappabeta family: intimate tales of association and dissociation"},{"title3":"IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex"},{"title3":"Stimulation-dependent Ikappabetaalpha phosphorylation marks the NFkappabeta inhibitor for degradation via the ubiquitin-proteasome pathway"},{"title3":"The ubiquitin-proteasome pathway is required for processing the NF-kappabeta1 precursor protein and the activation of NF-kappabeta"},{"title3":"The NFkappaB and IkappaB proteins: new discoveries and insights"},{"title3":"Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma"},{"title3":"Cross-Talk between Nuclear Factor-kappaB and the Steroid Hormone Receptors: Mechanisms of Mutual Antagonism"},{"title3":"The transcriptional activity of NF-kappabeta is regulated by the I-kappabeta-associated PKAc subunit through a cyclic AMP-independent mechanism"},{"title3":"Phosphorylation meets ubiquitination: the control of NF-kB activity"},{"title3":"A paradigm for gene regulation: inflammation, NF-kappaB and PPAR"},{"title3":"Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors"},{"title3":"Peroxisome proliferator-activated receptors and the control of inflammation"},{"title3":"Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis"},{"title3":"Regulation of cytokine receptor signaling by nuclear hormone receptors: a new paradigm for receptor interaction"},{"title3":"Statins and the prevention of dementia"},{"title3":"Small GTP-binding proteins"},{"title3":"The Ras superfamily at a glance"},{"title3":"New insights into the interaction of Ras with the plasma membrane"},{"title3":"Statins and angiotensin II-induced vascular injury"},{"title3":"RAS and leukemia: from basic mechanisms to gene-directed therapy"},{"title3":"Autocrine/Paracrine secretion of IL-6 family cytokines causes angiotensin II-induced delayed STAT3 activation"},{"title3":"Rac1 mediates STAT3 activation by autocrine IL-6"},{"title3":"Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation"},{"title3":"N-RAS gene activation in acute myeloid leukemia: association with expression of interleukin-6"},{"title3":"Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors"},{"title3":"Prenylation inhibitors in renal disease"},{"title3":"Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells"},{"title3":"Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase"},{"title3":"New insights into the molecular mechanisms of action of bisphosphonates"},{"title3":"Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs"},{"title3":"Polyphenols: food sources and bioavailability"},{"title3":"Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells"},{"title3":"Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6"},{"title3":"Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation"},{"title3":"Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor"},{"title3":"Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells"},{"title3":"Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions"},{"title3":"Thrombin induces interleukin-6 expression through the cAMP response element in vascular smooth muscle cells"},{"title3":"The role of interleukin 6 in megakaryocyte formation, megakaryocyte development and platelet production"},{"title3":"Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabolism"},{"title3":"Effects of interleukin 6 on megakaryocytes and on canine platelet function"},{"title3":"Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells"},{"title3":"A new immunological marker of atherosclerotic injury of arterial wall"},{"title3":"Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin"},{"title3":"Experimental and clinical pharmacology: bisphosphonates-mechanisms of action"},{"title3":"[Bisphosphonate therapy in osteoporosis. Inhibition of trabecular perforation by aminobisphosphonate]"},{"title3":"Clodronate treatment reduces serum levels of interleukin-6 soluble receptor in Paget's disease of bone"},{"title3":"Etidronate inhibits the production of IL-6 by osteoblast-like cells"},{"title3":"Bisphosphonates inhibit IL-6 production by human osteoblast-like cells"},{"title3":"Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption"},{"title3":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin"},{"title3":"Long-term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myeloma"},{"title3":"Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation"},{"title3":"Anti-inflammatory mode of isoflavone glycoside sophoricoside by inhibition of interleukin-6 and cyclooxygenase-2 in inflammatory response"},{"title3":"Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells"},{"title3":"Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity"},{"title3":"Suppression of tyrosine kinase activity inhibits [3H]thymidine uptake in cultured human pituitary tumor cells"},{"title3":"Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes"},{"title3":"Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade"},{"title3":"Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3.-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages"},{"title3":"Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice"},{"title3":"The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6"},{"title3":"Epigallocatechin, a Green Tea Polyphenol, Attenuates Myocardial Ischemia Reperfusion Injury in Rats"},{"title3":"Neutrophil restraint by green tea: Inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis"},{"title3":"Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action"},{"title3":"Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures"},{"title3":"Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells"},{"title3":"Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition"},{"title3":"Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-gamma but not by IL-4"},{"title3":"n-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production"},{"title3":"Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6"},{"title3":"ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness"},{"title3":"Atherosclerosis measured by B-mode ultrasonography: effect of statin therapy on disease progression"},{"title3":"Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes"},{"title3":"The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on necrosis of atherosclerotic lesions"},{"title3":"Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein"},{"title3":"Genistein supplementation inhibits atherosclerosis with stabilization of the lesions in hypercholesterolemic rabbits"},{"title3":"Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells"},{"title3":"Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone"},{"title3":"Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells"},{"title3":"A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus"},{"title3":"Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro"},{"title3":"Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling"},{"title3":"Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial"},{"title3":"A coronary primary prevention study of Scottish men aged 45-64 years: trial design. The West of Scotland Coronary Prevention Study Group"},{"title3":"Atorvastatin induces insulin sensitization in Zucker lean and fatty rats"},{"title3":"Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice"},{"title3":"Beneficial role of dietary phytoestrogens in obesity and diabetes"},{"title3":"Beneficial effects of soy phytoestrogen intake in postmenopausal women with Type 2 diabetes"},{"title3":"Beneficial role of dietary phytoestrogens in obesity and diabetes"},{"title3":"Soy Isoflavones Exert Antidiabetic and Hypolipidemic Effects through the PPAR Pathways in Obese Zucker Rats and Murine RAW 264.7 Cells"},{"title3":"Potential utility of natural polyphenols for reversing fat-induced insulin resistance"},{"title3":"Docosahexanoic acid (DHA) improved glucose and lipid metabolism in KK-Ay mice with genetic non-insulin-dependent diabetes mellitus (NIDDM)"},{"title3":"Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids form rheumatoid arthritis patients are responsible for osteoclast-like cell formation"},{"title3":"Interleukin 6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides"},{"title3":"Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients"},{"title3":"Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis"},{"title3":"Osteoclast function in Paget's disease and multiple myeloma"},{"title3":"Imaging of multiple myeloma"},{"title3":"Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma"},{"title3":"Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma"},{"title3":"Cytokine-induced production of IFN-beta2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17beta"},{"title3":"Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density"},{"title3":"Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced Cytokine expression in post-menopausal osteoporosis"},{"title3":"Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative"},{"title3":"Effect of surgical menopause and estrogen replacement on Cytokine release from human blood mononuclear cells"},{"title3":"Spontaneous release of interleukin-1 and interleukin-6 by peripheral blood mononuclear cells after oophorectomy"},{"title3":"17beta-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens"},{"title3":"17beta-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens)"},{"title3":"Increased osteoclast development after estrogen loss: Mediation by interleukin-6"},{"title3":"Development of bisphosphonates"},{"title3":"Bisphosphonate mechanism of action"},{"title3":"Bisphosphonate mechanism of action"},{"title3":"HMG CoA reductase inhibitors and the skeleton: a comprehensive review"},{"title3":"Effect of HMG-CoA reductase inhibitors (statins) on bone mineral density"},{"title3":"Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study"},{"title3":"The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity"},{"title3":"Decreased bone resorption with soy isoflavone supplementation in postmenopausal women"},{"title3":"Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy"},{"title3":"Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice"},{"title3":"Aging, longevity, inflammation, and cancer"},{"title3":"Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival"},{"title3":"Chronic stress and age-related increases in the proinflammatory cytokine IL-6"},{"title3":"Ultraviolet light induces increased circulating interleukin-6 in humans"},{"title3":"UV-induced NF-kappaB activation and expression of IL-6 is attenuated by (-)-epigallocatechin-3-gallate in cultured human keratinocytes in vitro"},{"title3":"Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers"},{"title3":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis"},{"title3":"A greater variability in the 3' flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE)"},{"title3":"Polymorphisms of the interleukin-6 gene are associated with bone mineral density"},{"title3":"Mevalonate-independent pathway of isoprenoids synthesis: A potential target in some human pathogens"}]},{"title2":"Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials.","References":[]},{"title2":"Inflammation and alzheimer's disease: possible role of periodontal diseases.","References":[]},{"title2":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China.","References":[]},{"title2":"Experience of clinical management for pregnant women and newborns with novel coronavirus pneumonia in tongji hospital, China.","References":[{"title3":"A case report of neonatal COVID-19 infection in China [J/OL]"},{"title3":"Chinese guidelines for diagnosis and treatment of HIV/AIDS (2018) (Chinese)"},{"title3":"Expert recommendations for the prevention and control of 2019 novel coronavirus infection in neonatal department"},{"title3":"World Health Organization. Home care for patients with suspected novel coronavirus (2019-nCoV) infection presenting with mild symptoms and management of contacts: Interim guidance [EB/OL]. [2020-02-04]."},{"title3":"Centers for Disease Control and Prevention. Prevention of the transmission of novel coronavirus (2019-nCoV) to families and communities in 2019: Interim guidance [R/OL]."},{"title3":"Expert suggestion on novel coronavirus infection during pregnancy and postpartum period (Chinese)"}]}]},{"title1":"Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study","References":[{"title2":"COVID-19 and older adults: What we know","References":[{"title3":"COVID-19 and older adults: what we know"},{"title3":"Use of rennin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19"},{"title3":"Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"SARSCoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Coronavirus disease 2019 in geriatrics and long-term care: The ABCDs of COVID-19","References":[]},{"title2":"AGS position statement: Resource allocation strategies and age-related considerations in the COVID-19 era and beyond","References":[{"title3":"Facing COVID-19 in Italy:ethics, logistics, and therapeutics on the epidemic's front line"},{"title3":"  . SIAARTI Web site. Clinical ethics recommendations for the allocation of intensive care treatments, in exceptional, resource-limited circumstances. http://www.siaarti.it/SiteAssets/News/COVID19%20-%20documenti%20SIAARTI/SIAARTI%20-%20Covid-19%20-%20Clinical%20Ethics%20Reccomendations.pdf. Accessed April 29, 2020."},{"title3":"A framework for rationing ventilators and critical care beds during the COVID-19 pandemic"},{"title3":"Fair allocation of scarce resources in the time of COVID-19"},{"title3":"The toughest triage:allocating ventilators in a pandemic"},{"title3":"Utah Crisis Standards of Care Guidelines. Version 2, June 2018. Utah.gov Web site. https://coronavirus.utah.gov/wp-content/uploads/Final_Utah_Crisis_Standards_of_Care_011719-1.pdf. Accessed May 2, 2020."},{"title3":"Triage: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement"},{"title3":"Rationing limited health care resources in the COVID-19 era and beyond: ethical considerations regarding older adults"},{"title3":"  . Advance care planning: ensuring your wishes are known and honored if you are unable to speak for yourself. CDC Web site. https://www.cdc.gov/aging/pdf/advanced-care-planning-critical-issue-brief.pdf. Accessed April 29, 2020."},{"title3":"  . https://prepareforyourcare.org. Accessed April 29, 2020. "},{"title3":"  . https://www.vitaltalk.org. Accessed April 29, 2020."},{"title3":"The age-friendly health system imperative"},{"title3":" , . Denying ventilators to COVID-19 patients with prior DNR orders is unethical. The Hastings Center Web site. https://www.thehastingscenter.org/denying-ventilators-to-covid-19-patients-with-prior-dnr-orders-is-unethical. Accessed April 29, 2020."},{"title3":" , , , . Gauging aging: mapping the gaps between expert and public understandings of aging in America. FrameWorks Institute Web site. http://www.frameworksinstitute.org/assets/files/aging_mtg.pdf. Accessed April 29, 2020."},{"title3":"  . Gaining momentum: A FrameWorks communications toolkit. FrameWorks Institute Web site. http://www.frameworksinstitute.org/toolkits/aging. Accessed April 29, 2020."},{"title3":" , . &quot;You only pray that somebody would step in&quot;: mapping the gaps between expert and public understandings of elder abuse in America. FrameWorks Institute Web site. https://www.frameworksinstitute.org/assets/files/elder_abuse_mtg_report_formatted_final.pdf. Accessed April 29, 2020."},{"title3":"Rules against age discrimination. 45 CFR 91.11 et seq. https://www.govinfo.gov/content/pkg/CFR-2019-title45-vol1/xml/CFR-2019-title45-vol1-part91.xml#seqnum91.11. Accessed April 23, 2020."},{"title3":"Functional trajectories among older persons before and after critical illness"},{"title3":"Multiple chronic conditions and life expectancy: a life table analysis"},{"title3":"Causes and consequences of comorbidity: a review"},{"title3":"The association of frailty with post-ICU disability, nursing home admission, and mortality: a longitudinal study"},{"title3":"Frailty and subsequent disability and mortality among patients with critical illness"},{"title3":"Coronavirus disease 2019 in geriatrics and long-term care: the ABCDs of COVID-19"},{"title3":"  . Develop a care plan. https://www.cdc.gov/aging/develop-care-plan.html. Accessed April 29, 2020."},{"title3":"The importance of addressing advance care planning and decisions about do-not-resuscitate orders during novel coronavirus 2019 (COVID-19)"},{"title3":"  . Age-friendly health systems: guide to using the 4Ms in the care of older adults. http://www.ihi.org/Engage/Initiatives/Age-Friendly-Health-Systems/Documents/IHIAgeFriendlyHealthSystems_GuidetoUsing4MsCare.pdf. Accessed April 29, 2020."},{"title3":" De facto health-care rationing by age"}]},{"title2":"Rationing limited health care resources in the COVID-19 era and beyond: Ethical considerations regarding older adults","References":[]},{"title2":"COVID-19 in Italy: Ageism and decision making in a pandemic","References":[{"title3":"WHO Director-General's opening remarks at the media briefing on COVID-19:11 March 2020"},{"title3":"Clinical ethics recommendations for the allocation of intensive care treatments, in exceptional, resource-limited circumstances"},{"title3":"Grandi insufficienze d'organo &quot;end stage&quot;: Cure intensive o cure palliative? Documento condiviso per una pianificazione delle scelte di cura. 2013"},{"title3":"Prognostic indices for older adults: A systematic review"},{"title3":"The central role of prognosis in clinical decision making"},{"title3":"Frailty and multimorbidity: Different ways of thinking about geriatrics"},{"title3":"Evidence for the domains supporting the construct of intrinsic capacity"},{"title3":"A global clinical measure of fitness and frailty in elderly people"},{"title3":"A diagnosis of dismobility:Giving mobility clinical visibility: A Mobility Working Group recommendation"}]},{"title2":"Ventilator triage policies during the COVID-19 pandemic at U.S. Hospitals Associated With Members of the Association of Bioethics Program Directors","References":[]},{"title2":"Universal do-not-resuscitate orders, social worth, and life-years: Opposing discriminatory approaches to the allocation of resources during the COVID-19 pandemic and other health system catastrophes","References":[]},{"title2":"NICE guideline [NG159]: COVID-19 rapid guideline: Critical care in adults","References":[]},{"title2":"Complementing chronic frailty assessment at hospital admission with an electronic frailty index (FI-Laboratory) comprising routine blood test results","References":[]},{"title2":"The impact of frailty on intensive care unit outcomes: A systematic review and meta-analysis","References":[{"title3":"Frailty in elderly people"},{"title3":"The rate of aging: the rate of deficit accumulation does not change over the adult life span"},{"title3":"A global clinical measure of fitness and frailty in elderly people"},{"title3":"Validation of an index to estimate the prevalence of frailty among community-dwelling seniors"},{"title3":"Superiority of frailty over age in predicting outcomes among geriatric trauma patients: a prospective analysis"},{"title3":"Redefining geriatric preoperative assessment using frailty, disability and co-morbidity"},{"title3":"Inflammation and frailty in the elderly: a systematic review and meta-analysis"},{"title3":"Frailty is associated with the epigenetic clock but not with telomere length in a German cohort"},{"title3":"Frailty in older adults: evidence for a phenotype"},{"title3":"Development of a frailty index for patients with coronary artery disease"},{"title3":"Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care"},{"title3":"How should we grade frailty in nursing home patients?"},{"title3":"Outcome instruments to measure frailty: a systematic review"},{"title3":"A scoping review of frailty and acute care in middle-aged and older individuals with recommendations for future research"},{"title3":"Frailty is associated with postoperative complications in older adults with medical problems"},{"title3":"Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study"},{"title3":"Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery"},{"title3":"Frailty in the critically ill: a novel concept"},{"title3":"The challenge of admitting the very elderly to intensive care"},{"title3":"Waters BVA, Bagshaw S, Boyd J, Maslove D, Sibley S, Rockwood E, Muscedere J (2017) The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. Intensive Care Med Exp, September abstract supplementary issue (in press)"},{"title3":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group"},{"title3":"Waters B, Varambally A, Muscedere J (2017) The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. https://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016053910. Accessed 1 June 2017"},{"title3":"Wells GABS, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohrica/programs/clinical_epidemiology/oxfordasp. Accessed 1 Jan 2017"},{"title3":"Estimating the mean and variance from the median, range, and the size of a sample"},{"title3":"Quantifying heterogeneity in a meta-analysis"},{"title3":"Association between frailty and short- and long-term outcomes among critically ill patients: a multicentre prospective cohort study"},{"title3":"Kizilarslanoglu MC, Civelek R, Kilic MK, Sumer F, Varan HD, Kara O, Arik G, Turkoglu M, Aygencel G, Ulger Z (2017) Is frailty a prognostic factor for critically ill elderly patients? Aging Clin Exp Res 29:247-255"},{"title3":"Prevalence and impact of frailty on mortality in elderly ICU patients: a prospective, multicenter, observational study"},{"title3":"Can sarcopenia quantified by ultrasound of the rectus femoris muscle predict adverse outcome of surgical intensive care unit patients as well as frailty? a prospective, observational cohort study"},{"title3":"Bedside frailty assessment and hospital outcomes in critically ill patients"},{"title3":"Predicting intensive care and hospital outcome with the Dalhousie Clinical Frailty Scale: a pilot assessment"},{"title3":"Brummel NE, Bell SP, Girard TD, Pandharipande PP, Jackson JC, Morandi A, Thompson JL, Chandrasekhar R, Bernard GR, Dittus RS, Gill TM, Ely EW (2016) Frailty and subsequent disability and mortality among patients with critical illness. Am J Respir Crit Care Med. doi:10.1164/rccm.201605-0939OC"},{"title3":"Assessing the usefulness and validity of frailty markers in critically ill adults"},{"title3":"Mortality in relation to frailty in patients admitted to a specialized geriatric intensive care unit"},{"title3":"Recovery after critical illness in patients aged 80 years or older: a multi-center prospective observational cohort study"},{"title3":"The very elderly admitted to ICU: a quality finish?"},{"title3":"Frailty assessment and hospital outcomes in critically ill patients"},{"title3":"Accumulation of deficits as a proxy measure of aging"},{"title3":"Frailty in older adults: evidence for a phenotype"},{"title3":"Long-term association between frailty and health-related quality of life among survivors of critical illness: a prospective multicenter cohort study"},{"title3":"Significantly higher peripheral insulin-like growth factor-1 levels in patients with major depressive disorder or bipolar disorder than in healthy controls: a meta-analysis and review under guideline of PRISMA"},{"title3":"Screening for frailty in Canada's health care system: a time for action"},{"title3":"The frailty syndrome: definition and natural history"},{"title3":"Frailty: scaling from cellular deficit accumulation?"},{"title3":"Biology of frailty: modulation of ageing genes and its importance to prevent age-associated loss of function"},{"title3":"Frailty before critical illness and mortality for elderly medicare beneficiaries"},{"title3":"Assessment and utility of frailty measures in critical illness, cardiology, and cardiac surgery"},{"title3":"Disability and co-morbidity in relation to frailty: how much do they overlap?"},{"title3":"Mitnitski AB, Rutenberg AD, Farrell S, Rockwood K (2017) Aging, frailty and complex networks. Biogerontology. doi:10.1007/s10522-017-9684-x"},{"title3":"Network model of human aging: frailty limits and information measures"},{"title3":"Dynamical network model for age-related health deficits and mortality"},{"title3":"Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report"}]},{"title2":"Accuracy and reproducibility of low-dose submillisievert chest CT for the diagnosis of COVID-19","References":[{"title3":"Hosts and sources of endemic human coronaviruses"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Sensitivity of chest CT for COVID-19: comparison to RT-PCR"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Benefits and harms of CT screening for lung cancer: a systematic review"},{"title3":"Reduced lung-cancer mortality with volume CT screening in a randomized trial"},{"title3":"The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103"},{"title3":"Imaging profile of the COVID-19 infection: radiologic findings and literature review"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Chest CT Findings in Cases from the Cruise Ship &quot;Diamond Princess&quot; with Coronavirus Disease 2019 (COVID-19)"},{"title3":"Statistical methods for assessing agreement between two methods of clinical measurement"},{"title3":"Clinical practice. Acute pericarditis"},{"title3":"Diagnostic tests 4: likelihood ratios"},{"title3":"The human metapneumovirus: a case series and review of the literature"}]},{"title2":"COVID-19: Use of the clinical frailty scale for critical care decisions","References":[{"title3":"The toughest triage:allocating ventilators in a pandemic"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"COVID-19 presents high risk to older persons"},{"title3":"Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations"},{"title3":"COVID-19 is a disease of older people"},{"title3":"  . COVID-19 Rapid Guideline: Critical Care. 2020. www.nice.org.uk/guidance/ng159. Accessed April 6, 2020."},{"title3":"Validating a standardised approach in administration of the Clinical Frailty Scale in hospitalised older adults"},{"title3":"The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis"},{"title3":"Frailty in very old critically ill patients in Australia and New Zealand: a population-based cohort study"},{"title3":"Outcomes for frail very old patients in the ICU are remarkably good"},{"title3":"Frailty and intrinsic capacity: two distinct but related constructs"},{"title3":"Forging a frailty-ready healthcare system to meet population ageing"}]},{"title2":"Frailty in the face of COVID-19","References":[{"title3":"World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)"},{"title3":"World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)"},{"title3":"Frailty status at admission to hospital predicts multiple adverse outcomes"},{"title3":"World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). A global clinical measure of fitness and frailty in elderly people"},{"title3":"World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Frailty in very old critically ill patients in Australia and New Zealand: a population-based cohort study"},{"title3":"Clinical frailty adds to acute illness severity in predicting mortality in hospitalized older adults: an observational study"},{"title3":"Sex differences in frailty: a systematic review and meta-analysis"},{"title3":"Effect of smoking on the accumulation of deficits, frailty and survival in older adults: a secondary analysis from the Canadian study of health and aging"},{"title3":"Social vulnerability, frailty and mortality in elderly people"}]},{"title2":"Risk factors for mortality in 244 older adults with COVID-19 in Wuhan, China: A retrospective study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"  . Coronavirus Disease (COVID-19) Pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed April 22, 2020."},{"title3":"  . Update on COVID-19 as of 24:00 on 5 March. http://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml. Accessed April 22, 2020."},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Pneumonia in the elderly: a review of the epidemiology, pathogenesis, microbiology, and clinical features"},{"title3":"Community-acquired pneumonia in the elderly"},{"title3":"Pneumonia in the elderly: understanding the characteristics"},{"title3":"Effect of aging on respiratory system physiology and immunology"},{"title3":"Effects of influenza immunization on pneumonia in the elderly"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV"},{"title3":"Angiotensin converting enzyme 2 in the kidney"},{"title3":"Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors"},{"title3":"Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"}]},{"title2":"Epidemiology of COVID-19 in a long-term care facility in king county, Washington","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"COVID-19 in a long-term care facility : King County, Washington, February 27-March 9, 2020"},{"title3":"The REDCap Consortium: Building an International Community of Software Platform Partners."},{"title3":"Severe respiratory illness outbreak associated with human coronavirus NL63 in a long-term care facility."},{"title3":"Influenza in long-term care facilities."},{"title3":"Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility : King County, Washington, March 2020."},{"title3":". Proclamations re: Covid-19 ()."},{"title3":". Coronavirus disease 2019 (COVID-19) fact sheets ()."},{"title3":". Recommendations for long-term care facility directors re: COVID-19. March 10, 2020 ()."},{"title3":". Preparing for COVID-19: long-term care facilities, nursing homes. 2020 ()."}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","References":[]},{"title2":"A framework for rationing ventilators and critical care beds during the COVID-19 pandemic","References":[]},{"title2":"Israel ad hoc COVID 19 committee. Guidelines for care of older persons during a pandemic","References":[{"title3":"Health and health care in Israel: an introduction"},{"title3":"Health care challenges of an aging population in Israel (part of the Lancet Israel Country Series)"},{"title3":"Country profile: Israel"},{"title3":"The psychological impact of quarantine and how to reduce it: rapid review of the evidence"},{"title3":"Coronavirus19 in geriatrics and long-term care: an update"},{"title3":"Development of a triage protocol or critical care during an influenza pandemic"},{"title3":"Ethical issues in end-of-life geriatric care: the approach of three monotheistic religions: Judaism, Catholicism and Islam"},{"title3":"  Rationing During a Flu Epidemic. https://www.yu.edu/sites/default/files/legacy//uploadedFiles/Academics/Seminary/RIETS/Programs/Jewish_Medical_Ethics/Verapo_Yerapey/Rationing%20During%20a%20Pandemic%20Flu.pdf. ."},{"title3":"  . ICNRC Report on COVID-19 in Critical Care, Apr 4, 2020. file:///C:/Users/markclar/Downloads/ICNARC%20COVID-19%20report%202020-04-04.pdf%20(2).pdf. ."},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"The Eldicus prospective, observational study of triage decision making in European intensive care units: part II: intensive care benefit for the elderly"},{"title3":"The toughest triage : allocating ventilators in a pandemic"},{"title3":"Association of increasing use of mechanical ventilation among nursing home residents with advanced dementia and intensive care beds"}]},{"title2":"China's oldest coronavirus survivors","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"The 103-year-old! The oldest COVID-19 patient in Hubei was discharged from hospital. February 11, 2020. Accessed March 14, 2020. https://v.qq.com/x/page/e0932iivddl.html."},{"title3":"98-year-old COVID-19 patient discharged from hospital. Accessed March 8, 2020. http://en.people.cn/index.html."},{"title3":"AGE NO BARRIER Chinese pensioner aged 101 RECOVERS from coronavirus days after 98-year-old woman beat disease. March 5, 2020. Accessed March 8, 2020. https://www.thesun.co.uk/news/11107818/chinese-pensioner-101-recovers-coronavirus-after-98-woman-beat-disease/."}]},{"title2":"Frailty index predicts poor outcome in COVID-19 patients","References":[{"title3":"Frailty in elderly people"},{"title3":"The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis"},{"title3":"A standard procedure for creating a frailty index"},{"title3":"Comparing the prognostic value of geriatric health indicators: a population-based study"},{"title3":"Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation"}]},{"title2":"Risk factors of severe disease and efficacy of treatment in patients infected with COVID-19: A systematic review, meta-analysis and meta-regression analysis","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"A coefficient of agreement for nominal scales"},{"title3":"Extracorporeal membrane oxygenation in pregnant and postpartum women with H1N1-related acute respiratory distress syndrome: a systematic review and meta-analysis"},{"title3":"Extracorporeal membrane oxygenation in pregnant and postpartum women: a systematic review and meta-regression analysis"},{"title3":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review"},{"title3":"A basic introduction to fixed-effect and random-effects models for meta-analysis"},{"title3":"Metaprop: a Stata command to perform meta-analysis of binomial data"},{"title3":"Estimating the mean and variance from the median, range, and the size of a sample"},{"title3":"Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range"},{"title3":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials"},{"title3":"Bias in meta-analysis detected by a simple, graphical test"},{"title3":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations"},{"title3":"How to perform a meta-analysis with R: a practical tutorial"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV Infection"},{"title3":"Lactate dehydrogenase, a risk factor of severe COVID-19 patients"},{"title3":"Clinical characteristics and prognosis of community-acquired pneumonia in autoimmune disease-induced immunocompromised host: a retrospective observational study"},{"title3":"Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments"},{"title3":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Tocilizumab treatment in COVID-19: a single center experience"},{"title3":"COVID-19: combining antiviral and anti-inflammatory treatments"}]},{"title2":"Prediction for progression risk in patients with COVID-19 pneumonia: The CALL Score","References":[]},{"title2":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis","References":[]},{"title2":"Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: Retrospective cohort study","References":[{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"World health organization. Coronavirus disease (COVID-19) outbreak situation. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 22 March 2020."},{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention"},{"title3":"Features discriminating SARS from other severe viral respiratory tract infections"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients"},{"title3":"Consistent detection of 2019 novel coronavirus in saliva"},{"title3":"National Health and Family Planning Commission of the People's Republic of China. Guideline for Diagnosis and Treatment of SARS-CoV-2 (the sixth edition). www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. Accessed 19 February 2020."},{"title3":"Epidemiology and Relative Severity of Influenza Subtypes in Singapore in the Post-Pandemic Period from 2009 to 2010"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"He X, Lau EH, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. medRxiv 2020.20036707."},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"The aetiology, origins, and diagnosis of severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients"},{"title3":"Detection of SARS coronavirus in plasma by real-time RT-PCR"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Detection of severe acute respiratory syndrome coronavirus RNA in plasma during the course of infection"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health"},{"title3":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection"},{"title3":"Immunosenescence: Implications for response to infection and vaccination in older people"},{"title3":"Asians Do Not Exhibit Elevated Expression or Unique Genetic Polymorphisms for ACE2, the Cell-Entry Receptor of SARS-CoV-2"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"}]},{"title2":"Instruments for the detection of frailty syndrome in older adults: A systematic review","References":[{"title3":"Burden of frailty in the elderly population: perspectives for a public health challenge"},{"title3":"Psychometric properties of multicomponent tools designed to assess frailty in older adults: A systematic review"},{"title3":"Frailty in elderly people"},{"title3":"Frailty in older adults: evidence for a phenotype"},{"title3":"Prevalence of frailty in Latin America and the Caribbean: a systematic review and meta-analysis"},{"title3":"Prevalence of frailty in community-dwelling older persons: a systematic review"},{"title3":"Quality criteria were proposed for measurement properties of health status questionnaires"},{"title3":"The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) and how to select an outcome measurement instrument"},{"title3":"Outcome instruments to measure frailty: a systematic review"},{"title3":"The identification of frailty: a systematic literature review"},{"title3":"Screening tools for frailty in primary health care: a systematic review"},{"title3":"The frailty dilemma. Review of the predictive accuracy of major frailty scores"},{"title3":"Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review"},{"title3":"Measures of frailty in population-based studies: an overview"},{"title3":"Frailty assessment instruments: Systematic characterization of the uses and contexts of highly-cited instruments"},{"title3":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement"},{"title3":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration"},{"title3":"Evaluation of a self-report screening instrument to predict frailty outcomes in aging populations"},{"title3":"The validity of the Frail instrument in general practice"},{"title3":"Operationalizing a frailty index from a standardized comprehensive geriatric assessment"},{"title3":"Clinical global impression of change in physical frailty: development of a measure based on clinical judgement"},{"title3":"Evaluation of a frailty index based on a comprehensive geriatric assessment in a population based study of elderly Canadians"},{"title3":"A global clinical measure of fitness and frailty in elderly people"},{"title3":"Validity and reliability of the Edmonton Frail Scale"},{"title3":"The assessment of frailty in older people in acute care"},{"title3":"Validation and comparison of two frailty indexes: The MOBILIZE Boston study"},{"title3":"Validation of the Chinese-Canadian study of health and aging clinical frailty scale (CSHA-CFS) telephone version"},{"title3":"The construct validity of the Tilburg Frailty Indicator: Psychometric Properties"},{"title3":"A reliable measure of frailty for a community dwelling older population"},{"title3":"The psychometric properties of three self-report screening instruments for identifying frail older people in the community"},{"title3":"Detecting and categorizing frailty status in older adults using a self-report screening instrument. Archives of Gerontology &amp;"},{"title3":"The predictive validity of three self-report screening instruments for identifying frail older people in the community"},{"title3":"Use of the Mini Nutritional Assessment to detect frailty in hospitalised older people"},{"title3":"Measurement Properties of the Groningen Frailty Indicator in Home-Dwelling and Institutionalized Elderly People"},{"title3":"Development and Evaluation of a Modification of the Fried Frailty Criteria Using Population-Independent Cutpoints"},{"title3":"Multidimensional structure of the Groningen Frailty Indicator in community-dwelling older people"},{"title3":"The comprehensive frailty assessment instrument: Development, validity and reliability"},{"title3":"Validation of the Comprehensive Frailty Assessment Instrument against the Tilburg Frailty Indicator"},{"title3":"Feasibility of Using Information Derived from a Care Partner to Develop a Frailty Index Based on Comprehensive Geriatric Assessment"},{"title3":"Development of an instrument for the identification of frail older people as a target population for integrated care"},{"title3":"Danish version of the Tilburg Frailty Indicator:Translation, cross-cultural adaption and validity pretest by cognitive interviewing"},{"title3":"A self-reported screening tool for detecting community-dwelling older persons with frailty syndrome in the absence of mobility disability: the FiND questionnaire"},{"title3":"Screening for Frailty in Older Adults Using a Postal Questionnaire: Rationale, Methods, and Instruments Validation of the INTER- FRAIL Study"},{"title3":"A new operational definition of frailty: the Frailty Trait Scale"},{"title3":"Prevalence and outcomes of frailty in Korean elderly population: comparisons of a multidimensional frailty index with two phenotype models"},{"title3":"The psychometric qualities of the Groningen Frailty Indicator in Romanian community-dwelling old citizens"},{"title3":"Screening for frailty in elderly subjects living at home: validation of the Modified Short Emergency Geriatric Assessment (SEGAm) instrument"},{"title3":"A Frailty Instrument for primary care for those aged 75 years or more: findings from the Survey of Health, Ageing and Retirement in Europe, a longitudinal population-based cohort study (SHARE-FI75+)"},{"title3":"Development of a frailty measure for older adults: the frailty index for elders"},{"title3":"Cross-cultural adaptation and reliability testing of the Tilburg Frailty Indicator for optimizing care of Polish patients with frailty syndrome"},{"title3":"Content validation of the Tilburg Frailty Indicator from the perspective of frail elderly. A qualitative explorative study"},{"title3":"Portuguese version of the Tilburg Frailty Indicator: Transcultural adaptation and psychometric validation"},{"title3":"Validity and responsiveness of the FRAIL scale in a longitudinal cohort study of older Australian women"},{"title3":"The validation of a care partner-derived frailty index based upon comprehensive geriatric assessment (CP-FI-CGA) in emergency medical services and geriatric ambulatory care"},{"title3":"Construct validity of the Groningen Frailty Indicator established in a large sample of home-dwelling elderly persons: Evidence of stability across age and gender"},{"title3":"Assessing upper extremity motion: An innovative method to identify frailty"},{"title3":"Frailty Screening in the Community Using the FRAIL Scale"},{"title3":"Development and validation of an electronic frailty index using routine primary care electronic health record data"},{"title3":"Validation of the FRAIL scale in Mexican elderly: results from the Mexican Health and Aging Study"},{"title3":"The clinical frailty scale predicts functional decline and mortality when used by junior medical staff: a prospective cohort study"},{"title3":"Emergency general surgery specific frailty index: A validation study"},{"title3":"The Korean version of the FRAIL scale: clinical feasibility and validity of assessing the frailty status of Korean elderly"},{"title3":"Cross-Cultural Adaptation and Validation of the FRAIL Scale to Assess Frailty in Mexican Adults"},{"title3":"Motor performance tests as screening instruments for frailty in the older adults"},{"title3":"Validity of the Kihon Checklist for assessing frailty status. [Article]"},{"title3":"Assessing Upper-Extremity Motion: An Innovative, Objective Method to Identify Frailty in Older Bed-Bound Trauma Patients"},{"title3":"Validity and Reliability of the Polish Version of the Tilburg Frailty Indicator (TFI)"},{"title3":"Development and validation of the FRAGIRE tool for assessment an older person's risk for frailty"},{"title3":"Construct Validity of Four Frailty Measures in an Older Australian Population: A Rasch Analysis"},{"title3":"Fried LP, Tangen Cm Fau:Walston J, Walston J Fau:Newman AB, Newman Ab Fau:Hirsch C, Hirsch C Fau:Gottdiener J, Gottdiener J Fau:Seeman T, et al. Frailty in older adults: evidence for a phenotype. 2001;(1079-5006 (Print))."},{"title3":"Relative fitness and frailty of elderly men and women in developed countries and their relationship with mortality"},{"title3":"Ensrud KE, Ewing SK, Taylor BC,; FHA, Cawthon PM, Stone KL, et al. Comparison of 2 Frailty Indexes for Prediction of Falls, Disability, Fractures, and Death in Older Women. 2008."},{"title3":"Development of an easy prognostic score for frailty outcomes in the aged"},{"title3":"A Frailty Instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE)"},{"title3":"Frailty syndrome diagnosed according to the Study of Osteoporotic Fractures (SOF) criteria and adverse health outcomes among community-dwelling older outpatients in Italy. A one-year prospective cohort study"},{"title3":"The SHARE operationalized frailty phenotype: a comparison of two approaches"},{"title3":"Accumulating deficits model of frailty and postoperative mortality and morbidity: its application to a national database"},{"title3":"Validating trauma-specific frailty index for geriatric trauma patients: a prospective analysis"},{"title3":"Construct validity and reliability of a two-step tool for the identification of frail older people in primary care"},{"title3":"Tilburg frailty indicator"},{"title3":"The Italian version of the Tilburg Frailty Indicator: analysis of psychometric properties"},{"title3":"The Italian version of the &quot;frailty index&quot; based on deficits in health: a validation study"},{"title3":"Screening for Frailty With the FRAIL Scale: A Comparison With the Phenotype Criteria"},{"title3":"Reliability and validity of the Tilburg Frailty Indicator (TFI) among Chinese community-dwelling older people"},{"title3":"Edmonton Frail Scale in Colombian older people. Comparison with the Fried criteria"},{"title3":"Frailty assessment in older adults using upper-extremity function: index development"},{"title3":"German translation, cross-cultural adaptation and diagnostic test accuracy of three frailty screening tools: PRISMA-7, FRAIL scale and Groningen Frailty Indicator"},{"title3":"Cross-Cultural Adaptation and Validation of the FRAIL Scale in Chinese Community-Dwelling Older Adults"},{"title3":"Cross-cultural adaptation and validation of the Comprehensive Frailty Assessment Instrument in Chinese community-dwelling older adults"},{"title3":"Psychometric properties of the Tilburg Frailty Indicator in older Spanish people"},{"title3":"Development, Construct Validity, and Predictive Validity of a Continuous Frailty Scale: Results From 2 Large US Cohorts"},{"title3":"Validation and translation of the Kihon Checklist (frailty index) into Brazilian Portuguese"},{"title3":"Accumulation of deficits as a proxy measure of aging"},{"title3":"Development of a frailty index for patients with coronary artery disease"},{"title3":"A 5-item frailty index based on NSQIP data correlates with outcomes following paraesophageal hernia repair"},{"title3":"PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities"},{"title3":"Use of the frailty index in evaluating the prognosis of older people in Beijing: a cohort study with an 8-year follow-up"},{"title3":"Analysis of survival in a sample of elderly patients from Ragusa, Italy on the basis of a primary care level multidimensional evaluation"},{"title3":"Novel Frailty Screening Questionnaire (FSQ) predicts 8-year mortality in older adults in China"},{"title3":"Cross-cultural adaptation and validity of the &quot;Edmonton frail scale:EFS&quot; in a Brazilian elderly sample"},{"title3":"Lindoso ZCL. Elaboracao de um instrumento multidimensional para o rastreio de sindrome da fragilidade em idosos atendidos na atencao primaria [tese]. Rio Grande do Sul Pontificia Universidade Catolica-PUCRS; 2012."},{"title3":"Borges CL. Adaptacao transcultural do instrumento Groningen Frailty Indicator em idosos brasileiros [Mestrado Academico em Cuidados Clinicos em Enfermagem]: Universidade Estadual do Ceara; 2013."},{"title3":"Reproducibility of the Brazilian version of the Edmonton Frail Scale for elderly living in the community"},{"title3":"Santiago LM. Fragilidade em idosos no Brasil: identificacao e analise de um instrumento de avaliacao para ser utilizado na populacao do pais [tese]: Escola Nacional de Saude Publica Sergio Arouca; 2013."},{"title3":"Psychometric properties of the brazilian version of the tilburg frailty indicator (TFI)"},{"title3":"Screening for frailty in older adults using a self-reported instrument"},{"title3":"Clinical-Functional Vulnerability Index-20 (IVCF-20): Rapid recognition of frail older adults"},{"title3":"Adaptacao transcultural para o Brasil do instrumento PRISMA-7: avaliacao das equivalencias conceitual, de item e semantica"},{"title3":"Research on screening for frailty: development of &quot;the Kaigo-Yobo Checklist&quot;"},{"title3":"The validity of the &quot;Kihon Check-list&quot; as an index of frailty and its biomarkers and inflammatory markers in elderly people"},{"title3":"Validity of the &quot;Kaigo-Yobo Check-List&quot; as a frailty index"},{"title3":"The validity and reliability of Korean frailty index"},{"title3":"Resources and risks in old age. The LUCAS-I marker set for a classification of elderly people as FIT, pre-FRAIL and FRAIL. first results on validity from the longitudinal urban cohort ageing study (LUCAS), Hamburg"},{"title3":"What can be done about inequalities in health?"},{"title3":"Social isolation, loneliness, and all-cause mortality in older men and women"},{"title3":"Frailty consensus: a call to action"},{"title3":"Searching for an operational definition of frailty: a Delphi method based consensus statement. The frailty operative definition-consensus conference project"},{"title3":"Risk of death in elderly persons based on the frailty phenotype and the frailty index: a review study"},{"title3":"The protective effect of neighborhood composition on increasing frailty among older Mexican Americans: a barrio advantage?"},{"title3":"Relationships between frailty, neighborhood security, social cohesion and sense of belonging among community-dwelling older people"},{"title3":"Ageing in place'? Exploring elderly people's housing preferences in Spain"},{"title3":"Transitions between states of disability and independence among older persons"},{"title3":"A program to prevent functional decline in physically frail, elderly persons who live at home"},{"title3":"Transitions between frailty states among community-living older persons"},{"title3":"Measurement of organ structure and function enhances understanding of the physiological basis of frailty: the Cardiovascular Health Study"},{"title3":"What are frailty instruments for?"},{"title3":"Frailty screening and assessment tools: a review of characteristics and use in Public Health"},{"title3":"Parametros psicometricos dos testes psicologicos"},{"title3":"Lack of social support in the etiology and the prognosis of coronary heart disease: a systematic review and meta-analysis"},{"title3":"Social disengagement and incident cognitive decline in community-dwelling elderly persons"},{"title3":"Measures of frailty in population-based studies: an overview"}]},{"title2":"Assessing frailty in the intensive care unit: A reliability and validity study","References":[]}]},{"title1":"Clinical characteristics and prognostic factors in COVID?19 patients aged ?80?years","References":[{"title2":"China medical treatment expert group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, Chnia","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Virology, epidemiology, pathogenesis, and control of COVID-19","References":[{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"The World Health Organization (WHO) Has Officially Named the Disease Caused by the Novel Coronavirus as COVID-19"},{"title3":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses:A statement of the Coronavirus Study Group"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Evolution and variation of 2019-novel coronavirus"},{"title3":"Decoding evolution and transmissions of novel pneumonia coronavirus using the whole genomic data"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Coronavirus pathogenesis"},{"title3":"Host Factors in Coronavirus Replication"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding"},{"title3":"Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China"},{"title3":"National Microbiology Data Center"},{"title3":"Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Structure, Function, and Evolution of Coronavirus Spike Proteins"},{"title3":"Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation"},{"title3":"Structure of dimeric full-length human ACE2 in complex with B0AT1"},{"title3":"Evolutionary insights into the ecology of coronaviruses"},{"title3":"Hosts and Sources of Endemic Human Coronaviruses"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China"},{"title3":"On the origin and continuing evolution of SARS-CoV-2"},{"title3":"Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China"},{"title3":"Positive RT-PCR Test Results in Patients Recovered From COVID-19"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"SARS-CoV-2 Infection in Children"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"An Update of Novel Coronavirus Pneumonia Outbreak as of 24:00 on February 12"},{"title3":"An Update of Novel Coronavirus Pneumonia Outbreak as of 24:00 on February 25"},{"title3":"An Update of Novel Coronavirus Pneumonia Outbreak as of 24:00 on March 23"},{"title3":"Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China"},{"title3":"The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection"},{"title3":"Two Things about COVID-19 Might Need Attention"},{"title3":"China Food and Drug Administration Emergency Approval of New Coronavirus Nucleic Acid Detection Reagents"},{"title3":"Xiamen University and Shenzhen Third Hospital Successfully Developed a Novel Coronavirus Antibody Detection kit, Which Can Improve the Clinical Diagnosis"},{"title3":"Field-deployable viral diagnostics using CRISPR-Cas13"},{"title3":"Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist"},{"title3":"A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19)"},{"title3":"Evidence for gastrointestinal infection of SARS-CoV-2"},{"title3":"Kidney impairment is associated with in-hospital death of COVID-19 patients"},{"title3":"Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection"},{"title3":"Pathological findings of COVID-19 associated with acuterespiratory distress syndrome"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): A report from China"},{"title3":"Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014"},{"title3":"Anatomy of a COVID-19 Death Corpse System"},{"title3":"Acute Respiratory Distress Syndrome"},{"title3":"Genetic heterogeneity and risk of acute respiratory distress syndrome"},{"title3":"Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Cell Pyroptosis, a Potential Pathogenic Mechanism of 2019-nCoV Infection"},{"title3":"The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice"},{"title3":"Antibody-dependent enhancement of viral infection: Molecular mechanisms and in vivo implications"},{"title3":"Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons"},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"Managing SARS amidst uncertainty"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures"},{"title3":"Effects of chloroquine on viral infections: An old drug against today's diseases?"},{"title3":"Potential antiviral therapeutics for 2019 Novel Coronavirus"},{"title3":"A human SARS-CoV neutralizing antibody against epitope on S2 protein"},{"title3":"Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia"},{"title3":"In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus"},{"title3":"SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development"},{"title3":"Design of multi epitope-based peptide vaccine against E protein of human 2019-nCoV: An immunoinformatics approach"},{"title3":"Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform"},{"title3":"The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice"},{"title3":"The Military Successfully Developed a Recombinant SARS-CoV-2 Vaccine"},{"title3":"American Moderna Vaccine enters Clinical Trial"}]},{"title2":"CMI Coronavirus disease 2019 (COVID-19) in Italy","References":[]},{"title2":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","References":[]},{"title2":"Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients","References":[{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERSepidemic"},{"title3":"COVID-19: lessons from SARS and MERS"},{"title3":"A systematic review of lopinavir therapy for sars coronavirus and mers coronavirus-a possible reference for coronavirus disease-19 treatment option"},{"title3":"Expert recommendations for tracheal intubation in critically ill patients with noval coronavirusdisease 2019"},{"title3":"Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV"},{"title3":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?"},{"title3":"Asymptomatic novel coronavirus pneumonia patient outside Wuhan: the value of CT images in the course of the disease"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novelcoronavirus disease"},{"title3":"Precautions in ophthalmic practice in the prevention and control of the novel coronaviruspneumonia epidemic"},{"title3":"Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer"}]},{"title2":"Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China","References":[{"title3":"Clinical diagnosis, treatment and prognosis of elderly SARS patients"},{"title3":"Fever response in elderly nursing home residents: are the older truly colder?"},{"title3":"Lowering the temperature criterion improves detection of infections in nursing home residents"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Early epidemiological and clinical characteristics of 28 cases of coronavirus disease in South Korea"},{"title3":"Older people and epidemics: a call for empathy"},{"title3":"Novel coronavirus (COVID-19) epidemic: what are the risks for older patients?"},{"title3":"Does the body temperature change in older people?"},{"title3":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia"},{"title3":"COVID-19 is a disease of older people"},{"title3":"Clinical features of deaths in the novel coronavirus epidemic in China"},{"title3":"Clinical feature of COVID-19 in elderly patients: a comparison with young and middle-aged patients"},{"title3":"A systematic review of body temperature variations in older people"},{"title3":"Prevalence, awareness, treatment, and control of hypertension in China: data from 1 7 million adults in a population-based screening study (China PEACE Million Persons Project)"},{"title3":"Action at a distance: geriatric research during a pandemic"},{"title3":"Fever in the elderly"},{"title3":"Individual differences in normal body temperature: longitudinal big data analysis of patient records"},{"title3":"Coronavirus infections: epidemiological, clinical and immunological features and hypotheses"},{"title3":"Basal body temperature as a biomarker of healthy aging"},{"title3":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013"},{"title3":"Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Prevalence and influencing factors of coronary heart disease and stroke in Chinese rural adults: the Henan rural cohort study"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Body temperature at the emergency department as a predictor of mortality in patients with bacterial infection"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Prevalence of chronic obstructive pulmonary disease in China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"}]},{"title2":"Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"The berlin definition of ARDS: an expanded rationale, justification, and supplementary material"},{"title3":"Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination"},{"title3":"Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) t cell responses. Curr==70=="},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"Middle east respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of Sars"},{"title3":"Middle east respiratory syndrome coronavirus efficiently infects human primary t lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"}]},{"title2":"Coronavirus infections-more than just the common cold","References":[]},{"title2":"Evidence of airborne transmission of the severe acute respiratory syndrome virus","References":[]},{"title2":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis","References":[{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Quality Appraisal of Case Series Studies Checklist"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Computed tomography features of patients with novel coronavirus pneumonia"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury (Chinese)"},{"title3":"CT features of patients with imported 2019-nCoV-pneumonia"},{"title3":"Preliminary explore on CT characteristics of coronavirus disease 2019 (COVID-19)"},{"title3":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China"},{"title3":"The epidemiological and clinical characteristics of 2019 novel coronavirus infection in Changsha, China"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing"},{"title3":"Analysis of CT features of 15 children with 2019 novel coronavirus infection"},{"title3":"Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Chest CT performance and clinical characteristics of coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical and epidemiological characteristics of 26 patients dia gnosed with novel coronavirus pneumonia"},{"title3":"Wang K, Kang SR, Tian RH, et al. CT characteristic appearances of patients with novel coronavirus pneumonia. J Clin Med. 2020;1(27):27-31."},{"title3":"Retrospective analysis of COVID-19 patients with different clinical subtypes"},{"title3":"CT findings in 2019 novel coronavirus disease (COVID-19) patients"},{"title3":"Application of chest CT examination in screening of patients with novel coronavirus pneumonia"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"CT manifestations and dynamic changes of coronavirus disease 2019"},{"title3":"Clinical diagnosis and treatment of critical patients with novel coronavirus pneumonia (report of 12 cases)"},{"title3":"Analysis of clinical and imaging features of novel coronavirus pneumonia in Chongqing traditional Chinese medicine system"},{"title3":"Clinical characteristics and CT signs of coronavirus disease 2019 (COVID-19) in the elderly"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Chest CT features of COVID-19"},{"title3":"Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia"},{"title3":"An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)"},{"title3":"Systematic solution of new coronavirus pneumonia in dead cadavers"},{"title3":"Study on the mechanism of liver enzyme abnormality in pneumonia infected by novel coronavirus"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Risk assessment of novel coronavirus COVID-19 outbreaks outside China"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"The neglected dimension of global security:a framework for countering infectious-disease crises"}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","References":[]},{"title2":"Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"  https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_28-aprile-2020.pdf Accessed on May 1 2020.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"SARS in Singapore - predictors of disease severity","References":[]},{"title2":"Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: the role of inflammatory biomarkers","References":[{"title3":"Inflammatory mechanisms in the lung"},{"title3":"Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality"},{"title3":"Deaths: Final Data for 2014"},{"title3":"Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults"},{"title3":"The LUNG SAFE study: a presentation of the prevalence of ARDS according to the Berlin Definition!"},{"title3":"A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU"},{"title3":"Factors associated with inflammatory cytokine patterns in community-acquired pneumonia"},{"title3":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials"},{"title3":"Interactions between respiratory epithelial cells and cytokines: relationships to lung inflammation"},{"title3":"Toll-like receptor function and signaling"},{"title3":"Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes"},{"title3":"Acute respiratory distress syndrome: pathophysiology and therapeutic options"},{"title3":"Role of the neutrophil in adult respiratory distress syndrome"},{"title3":"The interdependence of lung antioxidants and antiprotease defense in ARDS"},{"title3":"NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome"},{"title3":" Biomarker Terminology: Speaking The Same Language [Internet]. 2019"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS"},{"title3":"Chapter 6: Mechanisms of Innate Injury"},{"title3":"Laboratory Tests and Diagnostic Procedures. In: Laboratory tests and diagnostic procedures. 6th ed. St"},{"title3":"C-reactive protein and the acute phase response"},{"title3":"Biomarkers in community-acquired pneumonia: still searching for the one"},{"title3":"Procalcitonin: Uses in the Clinical Laboratory for the Diagnosis of Sepsis"},{"title3":"Use of plasma procalcitonin levels as an adjunct to clinical microbiology"},{"title3":"How and when to use common biomarkers in community-acquired pneumonia"},{"title3":"Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery"},{"title3":"Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia"},{"title3":"Initial Inflammatory Profile in Community-acquired Pneumonia Depends on Time since Onset of Symptoms"},{"title3":"Association of serum procalcitonin and C-reactive protein levels with CURB-65 criteria among patients with community-acquired pneumonia"},{"title3":"Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes"},{"title3":"Prognostic value of procalcitonin in community-acquired pneumonia"},{"title3":"The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia"},{"title3":"Serial procalcitonin levels for predicting prognosis in community-acquired pneumonia"},{"title3":"Consecutive Measures of CRP Correlate with Length of Hospital Stay in Patients with Community-Acquired Pneumonia"},{"title3":"Failure of CRP decline within three days of hospitalization is associated with poor prognosis of Community-acquired Pneumonia"},{"title3":"Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia"},{"title3":"A new method to predict hospital mortality in severe community acquired pneumonia"},{"title3":"Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial"},{"title3":"Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial"},{"title3":"Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial"},{"title3":"Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial"},{"title3":"Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia"},{"title3":"Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia"},{"title3":"Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine"},{"title3":"Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury"},{"title3":"Stability of ARDS subphenotypes over time in two randomised controlled trials"},{"title3":"Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies"},{"title3":"Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury"},{"title3":"Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury"},{"title3":"Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome"},{"title3":"Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis"},{"title3":"[Value of procalcitonin on predicting the severity and prognosis in patients with early ARDS: a prospective observation study]"},{"title3":"Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial"},{"title3":"Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs"},{"title3":"Glucocorticoids and inflammation revisited: the state of the art. NIH clinical staff conference"},{"title3":"Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy"},{"title3":"Acute Respiratory Distress Syndrome"},{"title3":"Patterns of cytokine expression in community-acquired pneumonia"},{"title3":"Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time"},{"title3":"Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature"},{"title3":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study"},{"title3":"Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis"},{"title3":"Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update"},{"title3":"Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis"},{"title3":"Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017"},{"title3":"Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis"},{"title3":"Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis"},{"title3":"Efficacy of corticosteroid treatment for severe community-acquired pneumonia: A meta-analysis"},{"title3":"Contemporary management of severe influenza disease in the intensive care unit"},{"title3":"Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome"},{"title3":"Early Corticosteroids for Pneumocystis Pneumonia in Adults Without HIV Are Not Associated With Better Outcome"},{"title3":"Factors associated with overall and attributable mortality in invasive aspergillosis"},{"title3":"Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality"},{"title3":"Factors associated with mortality in transplant patients with invasive aspergillosis"},{"title3":"Biomarker concordant steroid use in critically ill patients with pneumonia"},{"title3":"Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis"},{"title3":"Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature"},{"title3":"Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial"},{"title3":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome"},{"title3":"Timeliness of corticosteroid use in ICU patients with pneumonia and ARDS"},{"title3":"Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial"},{"title3":"Truwit JD, Bernard GR, Steingrub J, Matthay MA, Liu KD, Albertson TE, Brower RG, Shanholtz C, Rock P, Douglas IS, deBoisblanc BP, Hough CL, Hite RD, Thompson BT. Rosuvastatin for sepsis-associated acute respiratory distress syndrome"},{"title3":"Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis"},{"title3":"The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group"},{"title3":"Sevoflurane for Sedation in Acute Respiratory Distress Syndrome. A Randomized Controlled Pilot Study"},{"title3":"Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis"},{"title3":"Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study"},{"title3":"Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial"},{"title3":"Update on the combination effect of macrolide antibiotics in community-acquired pneumonia"},{"title3":"Macrolide antibiotics and survival in patients with acute lung injury"},{"title3":"Biomarkers in community-acquired pneumonia"}]},{"title2":"C-reactive protein levels in the early stage of COVID-19","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan. China: a descriptive study"},{"title3":"Asymptomatic novel coronavirus pneumonia patient outside Wuhan: the value of CT images in the course of the disease"},{"title3":"Early diagnosis of pneumonia in severe stroke: clinical features and the diagnostic role of C-reactive protein"},{"title3":"Covid-19 diagnostic and therapeutic regimen (trial 7th, edition)"},{"title3":"China coronavirus: mild but infectious cases may make it hard to control outbreak. Report warms"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"The novel Chinese coronavirus (2019-nCoV) infections: challenges for fighting the storm"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China"},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Emphasis and scientific evaluate the role of CT in the diagnosis and treatment of novel coronavirus pneumonia"},{"title3":"Pneumonia associated with 2019 novel coronavirus: can computed tomographic findings help predict the prognosis of the disease?"},{"title3":"Comparison of pre-and post-levothyroxine high-sensitivity C-reactive protein and fetuin-A levels in subclinical hypothyroidism"},{"title3":"Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: the role of inflammatory biomarkers"},{"title3":"Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure"}]},{"title2":"Dementia care during COVID-19","References":[{"title3":"Current understanding of Alzheimer's disease diagnosis and treatment"},{"title3":"Best practice in the management of behavioural and psychological symptoms of dementia"},{"title3":"Behavioral and psychological symptoms of dementia"},{"title3":"Agitation and dementia: Prevention and treatment strategies in acute and chronic conditions"},{"title3":"Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia"},{"title3":"Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia"},{"title3":"Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition"},{"title3":"Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition"},{"title3":"Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence"},{"title3":"Quality of life in dementia: More than just cognition. An analysis of associations with quality of life in dementia"},{"title3":"Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: The Cache County Dementia Progression Study"},{"title3":"Neuropsychiatric symptoms and the risk of institutionalization and death: The aging, demographics, and memory study"},{"title3":"Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community"},{"title3":"The influence of the individual neuropsychiatric symptoms of people with Alzheimer disease on family caregiver distress-A longitudinal ALSOVA study"},{"title3":"The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease"},{"title3":"The American Psychiatric Association Practice Guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia"},{"title3":"The agitated older adult in the emergency department: A narrative review of common causes and management strategies"},{"title3":"Managing delirium and agitation in the older emergency department patient: The ADEPT Tool"},{"title3":"Reduction and prevention of agitation in persons with neurocognitive disorders: An international psychogeriatric association consensus algorithm"},{"title3":"Pharmacological management of agitation in emergency settings"},{"title3":"Pharmacological management of acute agitation"},{"title3":"Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia"},{"title3":"Use of benzodiazepines in Alzheimer's disease: A systematic review of literature"},{"title3":"Treatment options for acute agitation in psychiatric patients: Theoretical and empirical evidence"},{"title3":"Behavioral emergency in the elderly: A descriptive study of patients referred to an Aggression Response Team in an acute hospital"},{"title3":"Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia"},{"title3":"Pharmacologic management of agitation in patients with dementia"},{"title3":"Characterization of psychotropic PRN medications in a Canadian psychiatric intensive care unit"},{"title3":"In an emergency setting, what is the best intramuscular pharmacological treatment to give to an agitated geriatric patient?"},{"title3":"Impact of COVID-19 pandemic on mental health in the general population: A systematic review"},{"title3":"The COVID-19 pandemic's impact on older adults' mental health: Contributing factors, coping strategies, and opportunities for improvement"},{"title3":"The effect of COVID-19 isolation measures on the cognition and mental health of people living with dementia: A rapid systematic review of one year of quantitative evidence"},{"title3":"The effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis"},{"title3":"The effects of the COVID-19 pandemic on neuropsychiatric symptoms in dementia and carer mental health: An international multicentre study"},{"title3":"Behavioral and psychological effects of coronavirus disease-19 quarantine in patients with dementia"},{"title3":"Managing the impact of COVID-19 in nursing homes and long-term care facilities: An update"},{"title3":"Behavioral symptoms, depression symptoms, and medication use in Michigan nursing home residents with dementia during COVID-19"},{"title3":"Antipsychotic prescribing to people with dementia during COVID-19"},{"title3":"The course of neuropsychiatric symptoms and psychotropic drug use in Dutch nursing home patients with dementia during the first wave of COVID-19: A longitudinal cohort study"},{"title3":" Government of Ontario, Ontario Confirms First Case of Wuhan Novel Coronavirus, Government of Ontario, https://news.ontario.ca/en/release/55486/ontario-confirms-first-case-of-wuhan-novel-coronavirus, Accessed December 1, 2022."},{"title3":" Sunnybrook Health Sciences Centre, About Sunnybrook - Our Sites, https://sunnybrook.ca/content/?page=location, Accessed December 19, 2022."},{"title3":" Sunnybrook Veterans Centre, Sunnybrook - Resident and Family Information Guide,https://sunnybrook.ca/uploads/1/programs/veterans/sunnybrook-veterans-handbook-141103.pdf, Accessed December 19, 2022."},{"title3":" Sunnybrook Health Sciences Centre, Veterans Program - Dementia Care, https://sunnybrook.ca/content/?page=veterans-dementia-care-dorothy-macham-home, Accessed December 19, 2022."},{"title3":" Villa Charities, About Villa Colombo Toronto, https://www.villacharities.com/affilates/villa-colombo-toronto/about-villa-colombo-toronto/, Accessed December 19, 2022."},{"title3":" Government of Canada, Long-term facilities-based care, https://www.canada.ca/en/health-canada/services/home-continuing-care/long-term-facilities-based-care.html, Accessed April 1, 2023"},{"title3":" Canadian Institute for Health Information, Long-term care homes in Canada: How many and who owns them?https://www.cihi.ca/en/long-term-care-homes-in-canada-how-many-and-who-owns-them, Accessed April 1, 2023."},{"title3":" Government of Ontario, Paying for long-term care, https://www.ontario.ca/page/paying-long-term-care, Accessed April 1, 2023."},{"title3":"Increased prescribing of psychotropic medications to Ontario nursing home residents during the COVID-19 pandemic"},{"title3":"Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings"},{"title3":"COVID-19 epidemic in Argentina: Worsening of behavioral symptoms in elderly subjects with dementia living in the community"},{"title3":"Psychotropic drug prescription in nursing homes during the COVID-19 pandemic"},{"title3":"Impact of social isolation due to COVID-19 on health in older people: Mental and physical effects and recommendations"},{"title3":"Dementia and mental health during the COVID-19 pandemic: A systematic review"},{"title3":"Effects of COVID-19 pandemic confinement in patients with cognitive impairment"},{"title3":"Facing dementia during the COVID-19 outbreak"},{"title3":"Neuropsychiatric symptoms in elderly with dementia during COVID-19 pandemic: Definition, treatment, and future directions"},{"title3":" Public Health Agency of Canada, Infection prevention and control for COVID-19: Interim guidance for long term care homes, https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevent-control-covid-19-long-term-care-homes.html, Accessed December 21, 2022."},{"title3":"Amid the COVID-19 pandemic, meaningful communication between family caregivers and residents of long-term care facilities is imperative"},{"title3":"The effects of the 2020 COVID-19 lockdown on mood, behavior, and social and cognitive functioning in older long-term care residents"},{"title3":"The effectiveness of non-pharmacological interventions using information and communication technologies for behavioral and psychological symptoms of dementia: A systematic review and meta-analysis"},{"title3":"COVID-19 and Ontario's long-term care homes"},{"title3":"Position statement for mental health care in long-term care during COVID-19"},{"title3":"Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)"},{"title3":"Haloperidol plus promethazine for psychosis-induced aggression"},{"title3":"A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation"},{"title3":"Use of antipsychotics in patients with behavioral and psychological symptoms of dementia: Results of a Spanish Delphi Consensus"},{"title3":"Managing acute agitation and aggression in the world of drug shortages"},{"title3":"Hypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam"},{"title3":"Treatment of agitation with lorazepam in clinical practice: A systematic review"},{"title3":"Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department"},{"title3":"The old and the oldest-old: Do they have different perspectives on adjustment to aging? "},{"title3":"Antipsychotic use in dementia"},{"title3":"Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations"},{"title3":" UN News, COVID-19: China infection surge on agenda at WHO coronavirus meeting, United Nations, https://news.un.org/en/story/2023/01/1132132, Accessed January 20, 2023."}]},{"title2":"Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus","References":[]},{"title2":"Delirium in hospitalized older adults","References":[]},{"title2":"Epidemiology of COVID-19 in a long-term care facility in King County, Washington","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"COVID-19 in a long-term care facility : King County, Washington, February 27-March 9, 2020"},{"title3":"The REDCap Consortium: Building an International Community of Software Platform Partners."},{"title3":"Severe respiratory illness outbreak associated with human coronavirus NL63 in a long-term care facility."},{"title3":"Influenza in long-term care facilities."},{"title3":"Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility : King County, Washington, March 2020."},{"title3":". Proclamations re: Covid-19 ()."},{"title3":". Coronavirus disease 2019 (COVID-19) fact sheets ()."},{"title3":". Recommendations for long-term care facility directors re: COVID-19. March 10, 2020 ()."},{"title3":". Preparing for COVID-19: long-term care facilities, nursing homes. 2020 ()."}]},{"title2":"ADI offers advice and support during COVID-19","References":[]}]}]}